≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Short stature, not elsewhere classified

DOID EFO Endpoint Browser

E4_SHORT

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

909

4. Check minimum number of events

None

909

5. Include endpoints

None

909

6. Filter based on genotype QC (FinnGen only)

838

Control definitions (FinnGen only)

Control exclude
E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 838 484 354
Unadjusted period prevalence (%) 0.17 0.17 0.16
Median age at first event (years) 8.73 9.48 7.70

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
903
Matched controls
8366
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
832.3
317.9
302
5
H01AC01
ATC
somatropin; parenteral
807.6
310.9
296
5
E34.35
ICD-10 Finland
Abnormal growth retardation
1526.4
307.7
511
7
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
25.5
307.7
339
193
E34.30
ICD-10 Finland
Short stature NOS
+∞
236.3
222
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
166.6
159
*
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
+∞
162.3
155
*
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
+∞
127.8
123
*
301
Kela drug reimbursment
Growth hormone
270.8
122.8
126
5
E34.31
ICD-10 Finland
Short stature, prenatal disorder
1050.8
102.5
101
*
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
15.9
96.2
89
57
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.3
72.1
231
613
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
+∞
70.8
69
*
602
Kela drug reimbursment
Children's severe malnutrition
6.6
58.5
104
163
E34.3
ICD-10 Finland
Short stature, not elsewhere classified
+∞
51.1
50
*
E30.09
ICD-10 Finland
Delayed puberty NOS
395.1
40.2
41
*
E30.00
ICD-10 Finland
Familial delayed puberty
135.9
38.8
42
*
Z3226
NOMESCO Finland
Physiotherapist
2.6
36.1
277
1201
Z31.5
ICD-10 Finland
Genetic counselling
3.5
35.6
142
426
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.8
29.4
70
143
L02AE02
ATC
leuprorelin; implant, parenteral
11.9
28.2
30
24
Z3231
NOMESCO Finland
Registered nurse
2.2
28.1
374
2030
RD210, ,
NOMESCO Finland
3.7
27.4
96
263
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
27.2
264
1253
R62.0
ICD-10 Finland
Delayed milestone
3.5
26.3
101
294
BF20A, ,
NOMESCO Finland
258.4
26.1
27
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
24.6
135
485
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.0
22.5
111
375
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.2
21.2
213
1013
H02AB09
ATC
hydrocortisone; systemic
3.5
20.3
76
217
127
Kela drug reimbursment
Transplant complication
5.0
20.1
45
87
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
7.7
19.9
29
36
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.2
19.7
202
965
Z2445
NOMESCO Finland
Psychologist
2.4
19.7
150
631
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.1
19.4
56
133
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
19.4
110
400
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
25.7
19.3
27
10
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
19.3
332
1919
XA800
NOMESCO Finland
Neuropsychological investigation
2.8
19.3
110
401
A11CC03
ATC
alfacalcidol; systemic
5.4
19.2
39
69
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
94.7
18.0
20
*
E34.45
ICD-10 Finland
Abnormal growth increase
41.7
17.7
22
5
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.6
17.4
60
162
R4110
NOMESCO Finland
Physiotherapy
2.0
17.4
260
1424
ZXE00
NOMESCO Finland
One hour or less
1.9
17.4
376
2324
E22.80
ICD-10 Finland
Central precocious puberty
170.0
17.0
18
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
16.9
170
803
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.9
16.8
31
50
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
16.3
261
1459
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
16.2
16
*
Z2221
NOMESCO Finland
Medical doctor
1.9
16.0
264
1487
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.0
15.7
73
238
L04AA06
ATC
mycophenolic acid; systemic
4.7
15.4
37
76
R4190
NOMESCO Finland
Nutritional therapy
2.2
15.3
156
739
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.5
15.1
30
52
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
6.3
15.1
26
39
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.7
15.0
84
303
P05.1
ICD-10 Finland
Small for gestational age
5.8
14.9
28
46
K06.18
ICD-10 Finland
Another gingival hyperplasia
6.2
14.7
26
40
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.5
14.6
104
422
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
14.5
95
371
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
2.8
14.4
76
265
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
14.4
205
1094
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
14.3
166
825
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
14.2
283
1683
7834C
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]
75.5
14.1
16
*
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
12.5
14.1
25
19
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
3.0
14.1
66
216
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.6
14.0
48
129
RL140, ,
NOMESCO Finland
4.4
13.6
35
76
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.8
13.6
72
252
T10
ICPC
Growth delay
5.5
13.5
27
47
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
12.7
115
517
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
12.5
260
1555
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.0
12.2
56
181
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.1
12.1
52
162
Z2446
NOMESCO Finland
Social worker
1.9
11.9
170
903
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.1
11.9
33
76
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.3
11.6
24
43
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.4
11.5
86
356
XKC03
NOMESCO Finland
Water cystometry
5.8
11.3
21
34
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
11.2
165
885
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.9
11.1
52
170
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
11.0
174
954
L04AD01
ATC
ciclosporin; systemic
3.5
10.7
37
100
Z94.0
ICD-10 Finland
Kidney transplant status
4.6
10.7
26
54
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
4.1
10.7
30
70
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
4.2
10.7
29
66
XX4AW, ,
NOMESCO Finland
3.2
10.4
42
126
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
10.3
169
936
ZXD05
NOMESCO Finland
Urgent procedure
1.7
10.3
220
1317
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
3.8
10.2
32
81
ZXA10
NOMESCO Finland
Bilateral
1.9
10.2
151
811
E28.3
ICD-10 Finland
Primary ovarian failure
+∞
10.1
10
*
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
3.7
10.1
33
86
L04AX01
ATC
azathioprine; systemic
2.8
10.1
53
185
F83
ICD-10 Finland
Mixed specific developmental disorders
2.4
9.7
66
262
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
5.4
9.5
19
33
L04AA01
ATC
[U] ciclosporin
7.9
9.5
21
25
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.0
9.5
43
138
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
9.5
134
707
TJD20
NOMESCO Finland
Change of gastrostomy tube
4.4
9.4
24
52
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
4.2
9.4
25
56
E30.9
ICD-10 Finland
Disorder of puberty, unspecified
51.5
9.3
11
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.0
9.3
106
519
A12AA04
ATC
calcium carbonate; oral
5.3
9.2
19
34
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
9.1
69
287
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
93.6
9.1
10
*
2594A
ICD-9 Finland
Other endocrine disorders, Dwarfism, not elsewhere classified
+∞
9.1
9
*
E34.40
ICD-10 Finland
Constitutional tall stature
+∞
9.1
9
*
E30.8
ICD-10 Finland
Other disorders of puberty
+∞
9.1
9
*
K03.66
ICD-10 Finland
Tooth plaque
1.8
9.0
165
942
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
9.0
102
499
XF602
NOMESCO Finland
Bloodpressure monitoring
4.1
9.0
25
58
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.2
9.0
75
326
N18.8
ICD-10 Finland
Other chronic renal failure
5.1
9.0
19
35
ZY010
NOMESCO Finland
Hospital outpatient
1.9
8.9
115
588
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.0
8.8
102
502
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
4.6
8.8
21
43
ZXA05
NOMESCO Finland
Left side
2.0
8.8
104
517
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.7
8.8
47
166
Q87.19
ICD-10 Finland
Congenital malformation syndromes predominantly associated with short stature
34.4
8.7
11
*
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
3.8
8.6
26
64
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.0
8.6
101
500
121
Kela drug reimbursment
Severe hypofunction of sexual glands
9.4
8.6
17
17
Q87.14
ICD-10 Finland
Noonan's syndrome
22.5
8.6
12
5
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.5
8.5
52
196
BC00A, ,
NOMESCO Finland
10.0
8.4
16
15
UKC02
NOMESCO Finland
Cystoscopy
2.8
8.3
42
144
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.8
8.3
132
723
E30.1
ICD-10 Finland
Precocious puberty
25.8
8.2
11
*
H03AA01
ATC
levothyroxine sodium; systemic
1.9
8.1
101
510
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
7.7
8.1
18
22
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.7
8.1
26
67
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.1
8.0
81
381
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.5
7.9
425
3121
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
7.8
156
911
XJC10
NOMESCO Finland
Oesophageal pH monitoring
4.7
7.8
18
36
J45.1
ICD-10 Finland
Nonallergic asthma
1.9
7.8
104
539
L04AD02
ATC
tacrolimus; systemic
3.5
7.7
27
74
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.5
7.7
19
40
R5140
NOMESCO Finland
Monitoring the use of the aid
3.2
7.7
31
93
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
7.7
119
645
RL130, ,
NOMESCO Finland
3.4
7.7
28
79
R03BA02
ATC
budesonide; inhalant
1.7
7.6
157
925
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.1
7.6
78
368
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
7.6
137
778
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.6
7.5
45
168
XW000
NOMESCO Finland
Bone marrow biopsy
2.8
7.5
37
125
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
2.2
7.5
67
300
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
3.4
7.4
27
76
R03AC03
ATC
terbutaline; inhalant
2.0
7.4
82
398
H02AB04
ATC
methylprednisolone; systemic
2.3
7.4
59
252
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.1
7.3
31
96
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
3.0
7.3
32
101
A41.9
ICD-10 Finland
Sepsis, unspecified
2.8
7.3
37
127
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
7.0
7.2
17
23
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.4
7.2
48
189
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.5
7.2
288
1982
H65.3
ICD-10 Finland
Chronic mucoid otitis media
1.8
7.2
104
553
ZX120
NOMESCO Finland
Intravenous
2.0
7.0
74
353
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
7.0
185
1159
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.2
7.0
58
252
H52.0
ICD-10 Finland
Hypermetropia
2.3
7.0
53
222
NF1AA
NOMESCO Finland
Hip X-ray examination
3.4
6.9
25
70
137
Kela drug reimbursment
Uraemia requiring dialysis
5.8
6.8
18
29
R4120
NOMESCO Finland
Occupational therapy
2.0
6.7
74
358
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.5
6.7
41
155
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
7.4
6.7
15
19
Z99.2
ICD-10 Finland
Dependence on renal dialysis
7.4
6.7
15
19
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
7.4
6.7
15
19
FM2CE, ,
NOMESCO Finland
2.0
6.7
78
385
B03XA01
ATC
erythropoietin; parenteral
6.2
6.7
17
26
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.2
6.5
25
73
DFF00
NOMESCO Finland
Pure tone audiometry
2.2
6.5
55
241
A03FA02
ATC
cisapride; oral, rectal
2.7
6.5
34
119
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.7
6.5
33
114
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.1
6.4
57
255
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
3.5
6.3
21
56
RS220, ,
NOMESCO Finland
2.8
6.3
30
100
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.2
6.3
24
70
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
6.3
146
886
ZXA00
NOMESCO Finland
Right side
1.7
6.2
106
591
Q96.3
ICD-10 Finland
Mosaicism, 45,X/46,XX or XY
65.2
6.2
7
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.3
6.2
23
66
RT160, ,
NOMESCO Finland
3.3
6.2
23
66
C08CA02
ATC
felodipine; oral
6.4
6.1
15
22
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
6.1
42
168
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.9
6.1
28
91
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
13.4
6.1
10
7
R1260
NOMESCO Finland
Evaluation of communicative skills
3.1
6.1
25
76
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.1
6.1
56
254
E23.1
ICD-10 Finland
Drug-induced hypopituitarism
+∞
6.1
6
*
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
+∞
6.1
6
*
102
Kela drug reimbursment
Diabetes insipidus
+∞
6.1
6
*
5AB14, ,
NOMESCO Finland
6.9
6.1
14
19
WW500
NOMESCO Finland
Blood transfusion
2.5
6.1
38
146

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Measurement of bone age from hand and elbow using X-ray
NK6MA [2001308495]
1.6e+00
2.5e+00
—
1.0e+50
—
3.1e+00
3.5e+00
cases:6.21%
controls:1.34%
cases:5.86%
controls:0.53%
—
—
cases:9.40%
controls:0.00%
—
—
cases:6.18%
controls:0.31%
cases:15.78%
controls:0.57%
38
79
574
5820
38
33
611
6169
—
61
0
588
6202
—
40
19
607
6159
98
34
523
5913
Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
29775-4 [3014326]
1.7e+00
—
1.0e+50
1.0e+50
—
4.4e+00
4.1e+00
cases:1.96%
controls:0.37%
—
—
cases:4.31%
controls:0.00%
cases:3.70%
controls:0.00%
—
—
cases:13.45%
controls:0.19%
cases:19.81%
controls:0.42%
12
22
600
5877
—
28
0
621
6202
24
0
625
6202
—
87
12
560
6166
123
25
498
5922
Kidney transplant status
Z94.0 [45566477]
2.0e+00
1.8e+00
1.4e+00
—
1.8e+00
1.6e+00
1.3e+00
cases:2.61%
controls:0.36%
cases:2.47%
controls:0.44%
cases:1.54%
controls:0.39%
—
—
cases:1.85%
controls:0.32%
cases:2.47%
controls:0.49%
cases:1.93%
controls:0.55%
16
21
596
5878
16
27
633
6175
10
24
639
6178
—
12
20
637
6181
16
30
631
6148
12
33
609
5914
Pediatric Medicine
37 [38004477]
-4.3e-02
1.5e-01
-1.3e-01
6.1e+00
1.5e+00
1.3e+00
7.3e-01
cases:49.18%
controls:50.25%
cases:40.52%
controls:36.94%
cases:9.24%
controls:10.40%
cases:57.01%
controls:0.31%
cases:31.12%
controls:9.56%
cases:63.99%
controls:33.65%
cases:58.62%
controls:40.46%
301
2964
311
2935
263
2291
386
3911
60
645
589
5557
370
19
279
6183
202
593
447
5608
414
2079
233
4099
364
2406
257
3541
Other lack of expected normal physiological development
R62.8 [45534460]
1.6e+00
3.6e+00
—
—
1.0e+50
4.0e+00
—
cases:1.80%
controls:0.36%
cases:4.62%
controls:0.13%
—
—
—
—
cases:0.92%
controls:0.00%
cases:4.17%
controls:0.08%
—
—
11
21
601
5878
30
8
619
6194
—
—
6
0
643
6201
27
5
620
6173
—
Outpatient Visit
OP [9202]
-1.3e-03
2.2e-01
3.9e-02
5.7e+00
1.1e+00
9.4e-01
5.0e-01
cases:60.13%
controls:60.16%
cases:57.47%
controls:52.10%
cases:15.72%
controls:15.20%
cases:63.17%
controls:0.55%
cases:33.90%
controls:14.43%
cases:73.72%
controls:52.41%
cases:80.84%
controls:71.82%
368
3549
244
2350
373
3231
276
2971
102
943
547
5259
410
34
239
6168
220
895
429
5306
477
3238
170
2940
502
4271
119
1676
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
4.7e-01
1.0e+00
2.2e+00
—
2.6e+00
1.0e+00
1.1e+00
cases:9.31%
controls:6.05%
cases:12.17%
controls:4.66%
cases:4.62%
controls:0.55%
—
—
cases:4.93%
controls:0.39%
cases:8.66%
controls:3.33%
cases:23.99%
controls:9.62%
57
357
555
5542
79
289
570
5913
30
34
619
6168
—
32
24
617
6177
56
206
591
5972
149
572
472
5375
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
4.6e-01
1.4e+00
1.8e+00
1.0e+50
2.7e+00
1.0e+00
6.1e-01
cases:8.17%
controls:5.32%
cases:10.79%
controls:3.02%
cases:2.16%
controls:0.37%
cases:1.54%
controls:0.00%
cases:3.39%
controls:0.24%
cases:5.26%
controls:1.94%
cases:9.66%
controls:5.50%
50
314
562
5585
70
187
579
6015
14
23
635
6179
10
0
639
6202
22
15
627
6186
34
120
613
6058
60
327
561
5620
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
4.6e-01
1.1e+00
2.0e+00
—
2.5e+00
8.7e-01
9.2e-01
cases:10.62%
controls:7.00%
cases:14.18%
controls:5.16%
cases:4.62%
controls:0.63%
—
—
cases:4.93%
controls:0.44%
cases:8.81%
controls:3.88%
cases:23.99%
controls:11.15%
65
413
547
5486
92
320
557
5882
30
39
619
6163
—
32
27
617
6174
57
240
590
5938
149
663
472
5284
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
3.8e-01
1.4e+00
1.9e+00
1.0e+50
2.9e+00
7.2e-01
5.2e-01
cases:7.35%
controls:5.15%
cases:11.09%
controls:2.89%
cases:2.47%
controls:0.39%
cases:1.85%
controls:0.00%
cases:3.54%
controls:0.21%
cases:4.64%
controls:2.31%
cases:10.14%
controls:6.29%
45
304
567
5595
72
179
577
6023
16
24
633
6178
12
0
637
6202
23
13
626
6188
30
143
617
6035
63
374
558
5573
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
5.8e-01
8.9e-01
1.4e+00
—
2.6e+00
2.3e+00
1.4e+00
cases:3.27%
controls:1.85%
cases:3.24%
controls:1.35%
cases:0.92%
controls:0.23%
—
—
cases:2.47%
controls:0.19%
cases:5.87%
controls:0.65%
cases:6.28%
controls:1.56%
20
109
592
5790
21
84
628
6118
6
14
643
6188
—
16
12
633
6189
38
40
609
6138
39
93
582
5854
Pediatric Endocrinology
OMOP4822030 [45756809]
-2.2e-02
2.6e-01
-2.9e-02
—
2.5e+00
2.2e+00
1.9e+00
cases:3.10%
controls:3.17%
cases:3.54%
controls:2.76%
cases:0.92%
controls:0.95%
—
—
cases:7.55%
controls:0.65%
cases:23.80%
controls:3.35%
cases:32.85%
controls:6.57%
19
187
593
5712
23
171
626
6031
6
59
643
6143
—
49
40
600
6161
154
207
493
5971
204
391
417
5556
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
5.7e-01
1.2e+00
2.3e+00
1.0e+50
2.4e+00
1.8e-01
8.2e-01
cases:4.41%
controls:2.54%
cases:4.31%
controls:1.40%
cases:2.16%
controls:0.23%
cases:0.77%
controls:0.00%
cases:1.54%
controls:0.15%
cases:1.55%
controls:1.29%
cases:6.44%
controls:2.94%
27
150
585
5749
28
87
621
6115
14
14
635
6188
5
0
644
6202
10
9
639
6192
10
80
637
6098
40
175
581
5772
azathioprine; oral, parenteral
L04AX01 [21603927]
1.8e+00
1.6e+00
1.8e+00
—
1.6e+00
1.7e+00
1.4e+00
cases:3.27%
controls:0.54%
cases:3.08%
controls:0.64%
cases:0.77%
controls:0.13%
—
—
cases:0.77%
controls:0.16%
cases:3.25%
controls:0.62%
cases:2.90%
controls:0.76%
20
32
592
5867
20
40
629
6162
5
8
644
6194
—
5
10
644
6191
21
38
626
6140
18
45
603
5902
Other specified disorders involving the immune mechanism, not elsewhere classified
D89.89 [2000501403]
2.1e+00
2.3e+00
—
—
—
2.0e+00
1.6e+00
cases:1.31%
controls:0.17%
cases:1.23%
controls:0.13%
—
—
—
—
—
—
cases:1.24%
controls:0.16%
cases:1.29%
controls:0.27%
8
10
604
5889
8
8
641
6194
—
—
—
8
10
639
6168
8
16
613
5931
Celiac disease serology panel - Serum
94494-2 [36660697]
1.6e-01
1.8e+00
2.4e+00
1.0e+50
—
1.3e+00
8.5e-01
cases:2.12%
controls:1.81%
cases:5.55%
controls:0.95%
cases:1.39%
controls:0.13%
cases:0.92%
controls:0.00%
—
—
cases:2.16%
controls:0.62%
cases:6.12%
controls:2.71%
13
107
599
5792
36
59
613
6143
9
8
640
6194
6
0
643
6202
—
14
38
633
6140
38
161
583
5786
methylprednisolone; oral, parenteral
H02AB04 [21602732]
1.5e+00
1.5e+00
—
—
2.1e+00
1.1e+00
8.2e-01
cases:3.10%
controls:0.68%
cases:3.08%
controls:0.71%
—
—
—
—
cases:1.39%
controls:0.18%
cases:2.78%
controls:0.94%
cases:2.42%
controls:1.08%
19
40
593
5859
20
44
629
6158
—
—
9
11
640
6190
18
58
629
6120
15
64
606
5883
Physiotherapist
Z3226 [2001311560]
4.5e-01
7.5e-01
—
—
1.9e+00
1.4e+00
1.9e+00
cases:9.80%
controls:6.48%
cases:5.08%
controls:2.47%
—
—
—
—
cases:1.85%
controls:0.29%
cases:5.10%
controls:1.26%
cases:7.09%
controls:1.09%
60
382
552
5517
33
153
616
6049
—
—
12
18
637
6183
33
78
614
6100
44
65
577
5882
Predominantly allergic asthma
J45.0 [45557624]
1.0e+00
1.2e+00
1.2e+00
1.0e+50
1.6e+00
1.2e+00
8.8e-01
cases:7.84%
controls:3.02%
cases:6.32%
controls:2.02%
cases:0.92%
controls:0.29%
cases:2.62%
controls:0.00%
cases:1.69%
controls:0.35%
cases:6.65%
controls:2.07%
cases:8.05%
controls:3.50%
48
178
564
5721
41
125
608
6077
6
18
643
6184
17
0
632
6202
11
22
638
6179
43
128
604
6050
50
208
571
5739
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
2.3e+00
1.7e+00
—
—
—
1.8e+00
1.7e+00
cases:1.63%
controls:0.17%
cases:0.92%
controls:0.18%
—
—
—
—
—
—
cases:1.08%
controls:0.18%
cases:1.29%
controls:0.24%
10
10
602
5889
6
11
643
6191
—
—
—
7
11
640
6167
8
14
613
5933
Follitropin [Units/volume] in Serum or Plasma
15067-2 [3023323]
1.8e+00
1.4e+00
—
1.0e+50
—
2.1e+00
1.6e+00
cases:1.31%
controls:0.22%
cases:1.54%
controls:0.40%
—
—
cases:0.77%
controls:0.00%
—
—
cases:3.09%
controls:0.37%
cases:7.09%
controls:1.56%
8
13
604
5886
10
25
639
6177
—
5
0
644
6202
—
20
23
627
6155
44
93
577
5854
calcium (different salts in combination); oral
A12AA20 [21600872]
1.1e+00
1.5e+00
—
—
—
1.4e+00
1.4e+00
cases:2.78%
controls:0.90%
cases:2.00%
controls:0.45%
—
—
—
—
—
—
cases:1.85%
controls:0.47%
cases:4.67%
controls:1.21%
17
53
595
5846
13
28
636
6174
—
—
—
12
29
635
6149
29
72
592
5875
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
-8.0e-02
8.2e-02
7.6e-01
2.9e+00
1.2e+00
7.6e-01
6.1e-01
cases:5.39%
controls:5.81%
cases:4.62%
controls:4.27%
cases:1.54%
controls:0.73%
cases:1.39%
controls:0.08%
cases:2.00%
controls:0.63%
cases:5.87%
controls:2.85%
cases:8.05%
controls:4.52%
33
343
579
5556
30
265
619
5937
10
45
639
6157
9
5
640
6197
13
39
636
6162
38
176
609
6002
50
269
571
5678
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
-6.5e-02
3.0e-01
4.9e-01
2.7e+00
1.4e+00
7.6e-01
5.1e-01
cases:8.66%
controls:9.19%
cases:9.86%
controls:7.48%
cases:2.77%
controls:1.73%
cases:2.47%
controls:0.18%
cases:5.55%
controls:1.39%
cases:9.27%
controls:4.58%
cases:11.43%
controls:7.18%
53
542
559
5357
64
464
585
5738
18
107
631
6095
16
11
633
6191
36
86
613
6115
60
283
587
5895
71
427
550
5520
Allergic rhinitis due to pollen
J30.10 [2000502594]
7.4e-01
9.7e-01
—
1.0e+50
2.6e+00
9.1e-01
6.0e-01
cases:4.41%
controls:2.15%
cases:3.24%
controls:1.26%
—
—
cases:1.08%
controls:0.00%
cases:2.00%
controls:0.15%
cases:3.09%
controls:1.26%
cases:6.12%
controls:3.45%
27
127
585
5772
21
78
628
6124
—
7
0
642
6202
13
9
636
6192
20
78
627
6100
38
205
583
5742
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
-5.1e-02
-1.1e-03
6.4e-01
2.9e+00
1.1e+00
7.3e-01
5.4e-01
cases:5.56%
controls:5.83%
cases:4.62%
controls:4.63%
cases:1.54%
controls:0.82%
cases:1.69%
controls:0.10%
cases:2.16%
controls:0.74%
cases:6.18%
controls:3.09%
cases:8.05%
controls:4.88%
34
344
578
5555
30
287
619
5915
10
51
639
6151
11
6
638
6196
14
46
635
6155
40
191
607
5987
50
290
571
5657
Base excess in Venous blood by calculation
1927-3 [3002032]
-5.1e-02
-1.1e-03
6.4e-01
2.9e+00
1.1e+00
7.0e-01
5.4e-01
cases:5.56%
controls:5.83%
cases:4.62%
controls:4.63%
cases:1.54%
controls:0.82%
cases:1.69%
controls:0.10%
cases:2.16%
controls:0.74%
cases:6.03%
controls:3.08%
cases:8.05%
controls:4.88%
34
344
578
5555
30
287
619
5915
10
51
639
6151
11
6
638
6196
14
46
635
6155
39
190
608
5988
50
290
571
5657
Children's severe malnutrition
602 [2001600367]
1.1e+00
7.7e-01
—
—
—
2.1e+00
1.8e+00
cases:3.59%
controls:1.24%
cases:1.08%
controls:0.50%
—
—
—
—
—
—
cases:1.08%
controls:0.13%
cases:1.13%
controls:0.18%
22
73
590
5826
7
31
642
6171
—
—
—
7
8
640
6170
7
11
614
5936
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
4.1e-01
1.2e+00
1.7e+00
—
1.6e+00
4.8e-01
6.1e-01
cases:7.84%
controls:5.36%
cases:12.17%
controls:4.19%
cases:3.70%
controls:0.69%
—
—
cases:3.85%
controls:0.82%
cases:5.72%
controls:3.61%
cases:11.92%
controls:6.88%
48
316
564
5583
79
260
570
5942
24
43
625
6159
—
25
51
624
6150
37
223
610
5955
74
409
547
5538
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
2.8e-03
1.1e-01
4.5e-01
2.5e+00
1.3e+00
7.0e-01
5.4e-01
cases:5.07%
controls:5.05%
cases:6.16%
controls:5.56%
cases:2.00%
controls:1.29%
cases:1.85%
controls:0.16%
cases:3.85%
controls:1.10%
cases:7.26%
controls:3.74%
cases:9.18%
controls:5.55%
31
298
581
5601
40
345
609
5857
13
80
636
6122
12
10
637
6192
25
68
624
6133
47
231
600
5947
57
330
564
5617
Gas panel - Venous blood
24339-4 [3000991]
-1.0e-01
1.2e-01
5.3e-01
3.1e+00
1.2e+00
7.1e-01
5.5e-01
cases:5.07%
controls:5.59%
cases:4.62%
controls:4.11%
cases:1.23%
controls:0.73%
cases:1.69%
controls:0.08%
cases:2.16%
controls:0.68%
cases:5.56%
controls:2.82%
cases:7.25%
controls:4.30%
31
330
581
5569
30
255
619
5947
8
45
641
6157
11
5
638
6197
14
42
635
6159
36
174
611
6004
45
256
576
5691
Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
72873-3 [43534046]
—
1.8e+00
—
—
—
2.6e+00
2.2e+00
—
—
cases:0.77%
controls:0.13%
—
—
—
—
—
—
cases:1.55%
controls:0.11%
cases:2.42%
controls:0.29%
—
5
8
644
6194
—
—
—
10
7
637
6171
15
17
606
5930
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
-6.9e-02
2.9e-01
5.3e-01
2.6e+00
1.4e+00
7.5e-01
4.6e-01
cases:8.66%
controls:9.22%
cases:9.71%
controls:7.47%
cases:2.93%
controls:1.74%
cases:2.62%
controls:0.19%
cases:5.39%
controls:1.40%
cases:9.27%
controls:4.60%
cases:10.79%
controls:7.10%
53
544
559
5355
63
463
586
5739
19
108
630
6094
17
12
632
6190
35
87
614
6114
60
284
587
5894
67
422
554
5525
pH of Venous blood
2746-6 [3012544]
-4.8e-02
-1.1e-03
6.4e-01
2.9e+00
1.1e+00
7.3e-01
5.1e-01
cases:5.56%
controls:5.81%
cases:4.62%
controls:4.63%
cases:1.54%
controls:0.82%
cases:1.69%
controls:0.10%
cases:2.16%
controls:0.74%
cases:6.18%
controls:3.09%
cases:7.89%
controls:4.91%
34
343
578
5556
30
287
619
5915
10
51
639
6151
11
6
638
6196
14
46
635
6155
40
191
607
5987
49
292
572
5655
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
-6.1e-02
5.0e-01
8.1e-01
2.4e+00
8.5e-01
9.7e-02
2.6e-01
cases:11.27%
controls:11.90%
cases:15.72%
controls:10.13%
cases:4.93%
controls:2.26%
cases:2.16%
controls:0.19%
cases:4.93%
controls:2.18%
cases:8.19%
controls:7.49%
cases:18.20%
controls:14.65%
69
702
543
5197
102
628
547
5574
32
140
617
6062
14
12
635
6190
32
135
617
6066
53
463
594
5715
113
871
508
5076
Neuropsychological evaluation of need and possibilities to rehabilitation
R1230 [2001310176]
1.4e+00
1.9e+00
—
—
—
1.8e+00
8.6e-01
cases:1.14%
controls:0.29%
cases:1.23%
controls:0.19%
—
—
—
—
—
—
cases:2.01%
controls:0.32%
cases:3.38%
controls:1.46%
7
17
605
5882
8
12
641
6190
—
—
—
13
20
634
6158
21
87
600
5860
Laboratory Visit
OMOP4822461 [32036]
-1.1e-01
1.4e-01
5.2e-01
2.5e+00
1.1e+00
3.3e-01
1.3e-01
cases:19.44%
controls:21.29%
cases:24.50%
controls:22.03%
cases:10.32%
controls:6.39%
cases:6.47%
controls:0.56%
cases:14.48%
controls:5.58%
cases:25.66%
controls:19.89%
cases:35.27%
controls:32.30%
119
1256
493
4643
159
1366
490
4836
67
396
582
5806
42
35
607
6167
94
346
555
5855
166
1229
481
4949
219
1921
402
4026
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
-1.7e-02
4.4e-02
7.0e-01
3.0e+00
1.0e+00
8.0e-01
6.0e-01
cases:5.56%
controls:5.65%
cases:4.62%
controls:4.43%
cases:1.54%
controls:0.77%
cases:1.54%
controls:0.08%
cases:2.00%
controls:0.73%
cases:6.18%
controls:2.87%
cases:8.05%
controls:4.59%
34
333
578
5566
30
275
619
5927
10
48
639
6154
10
5
639
6197
13
45
636
6156
40
177
607
6001
50
273
571
5674
pH of Serum or Plasma
2753-2 [3018418]
6.2e-01
9.9e-01
—
—
2.3e+00
1.0e+00
5.4e-01
cases:3.27%
controls:1.78%
cases:3.85%
controls:1.47%
—
—
—
—
cases:1.69%
controls:0.18%
cases:3.09%
controls:1.17%
cases:4.83%
controls:2.88%
20
105
592
5794
25
91
624
6111
—
—
11
11
638
6190
20
72
627
6106
30
171
591
5776
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.3e-01
5.8e-01
7.2e-01
2.1e+00
8.4e-01
2.7e-01
1.8e-01
cases:11.44%
controls:10.17%
cases:14.79%
controls:8.88%
cases:4.47%
controls:2.23%
cases:1.54%
controls:0.19%
cases:5.24%
controls:2.34%
cases:9.58%
controls:7.48%
cases:16.75%
controls:14.34%
70
600
542
5299
96
551
553
5651
29
138
620
6064
10
12
639
6190
34
145
615
6056
62
462
585
5716
104
853
517
5094
Corticotropin [Mass/volume] in Plasma
2141-0 [3035637]
6.9e-01
6.2e-01
—
—
—
2.5e+00
1.7e+00
cases:1.31%
controls:0.66%
cases:1.08%
controls:0.58%
—
—
—
—
—
—
cases:4.02%
controls:0.34%
cases:3.86%
controls:0.72%
8
39
604
5860
7
36
642
6166
—
—
—
26
21
621
6157
24
43
597
5904
Medical doctor
Z2221 [2001311556]
4.3e-01
9.3e-01
—
—
—
1.7e+00
1.4e+00
cases:8.01%
controls:5.37%
cases:5.24%
controls:2.14%
—
—
—
—
—
—
cases:6.80%
controls:1.26%
cases:7.73%
controls:1.95%
49
317
563
5582
34
133
615
6069
—
—
—
44
78
603
6100
48
116
573
5831
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
4.1e-01
5.8e-01
1.2e+00
—
1.7e+00
5.9e-01
5.5e-01
cases:5.72%
controls:3.88%
cases:6.63%
controls:3.81%
cases:2.16%
controls:0.63%
—
—
cases:3.70%
controls:0.69%
cases:6.34%
controls:3.63%
cases:12.08%
controls:7.31%
35
229
577
5670
43
236
606
5966
14
39
635
6163
—
24
43
625
6158
41
224
606
5954
75
435
546
5512
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
2.6e-01
8.0e-01
1.2e+00
—
1.3e+00
5.4e-01
7.0e-01
cases:6.86%
controls:5.37%
cases:8.63%
controls:4.06%
cases:3.54%
controls:1.06%
—
—
cases:3.85%
controls:1.03%
cases:5.41%
controls:3.22%
cases:9.02%
controls:4.67%
42
317
570
5582
56
252
593
5950
23
66
626
6136
—
25
64
624
6137
35
199
612
5979
56
278
565
5669
methylphenidate; oral
N06BA04 [21604757]
9.8e-01
1.2e+00
1.1e+00
—
8.7e-01
1.2e+00
7.5e-01
cases:2.61%
controls:1.00%
cases:2.16%
controls:0.66%
cases:0.92%
controls:0.31%
—
—
cases:0.77%
controls:0.32%
cases:2.63%
controls:0.84%
cases:5.48%
controls:2.67%
16
59
596
5840
14
41
635
6161
6
19
643
6183
—
5
20
644
6181
17
52
630
6126
34
159
587
5788
formoterol, glycopyrronium bromide and budesonide
R03AL11 [715850]
2.1e+00
1.9e+00
—
—
—
1.2e+00
6.8e-01
cases:1.63%
controls:0.20%
cases:1.39%
controls:0.21%
—
—
—
—
—
—
cases:0.93%
controls:0.28%
cases:1.93%
controls:0.99%
10
12
602
5887
9
13
640
6189
—
—
—
6
17
641
6161
12
59
609
5888
Besnier prurigo
L20.0 [45562534]
6.6e-01
8.4e-01
—
—
1.9e+00
7.6e-01
6.1e-01
cases:6.70%
controls:3.59%
cases:4.31%
controls:1.92%
—
—
—
—
cases:1.85%
controls:0.29%
cases:3.71%
controls:1.76%
cases:6.44%
controls:3.60%
41
212
571
5687
28
119
621
6083
—
—
12
18
637
6183
24
109
623
6069
40
214
581
5733
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
-1.9e-01
2.8e-01
5.4e-01
2.3e+00
1.1e+00
5.2e-01
2.2e-01
cases:10.29%
controls:12.19%
cases:12.48%
controls:9.74%
cases:3.70%
controls:2.19%
cases:2.47%
controls:0.24%
cases:5.86%
controls:2.02%
cases:10.66%
controls:6.65%
cases:15.94%
controls:13.18%
63
719
549
5180
81
604
568
5598
24
136
625
6066
16
15
633
6187
38
125
611
6076
69
411
578
5767
99
784
522
5163
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
-1.8e-01
3.0e-01
5.6e-01
2.3e+00
1.1e+00
5.5e-01
2.3e-01
cases:10.29%
controls:12.05%
cases:12.48%
controls:9.56%
cases:3.70%
controls:2.14%
cases:2.31%
controls:0.24%
cases:5.55%
controls:1.97%
cases:10.66%
controls:6.44%
cases:15.94%
controls:13.10%
63
711
549
5188
81
593
568
5609
24
133
625
6069
15
15
634
6187
36
122
613
6079
69
398
578
5780
99
779
522
5168
Intravenous
ZX120 [2001311495]
5.9e-01
—
-1.0e+50
—
—
1.6e+00
2.2e+00
cases:2.94%
controls:1.64%
—
—
cases:0.00%
controls:0.21%
—
—
—
—
cases:1.55%
controls:0.31%
cases:2.09%
controls:0.24%
18
97
594
5802
—
0
13
649
6189
—
—
10
19
637
6159
13
14
608
5933
estradiol; nasal, oral, parenteral, rectal, transdermal, vaginal
G03CA03 [21602517]
—
—
—
—
—
1.9e+00
1.9e+00
—
—
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.16%
cases:2.90%
controls:0.45%
—
—
—
—
—
7
10
640
6168
18
27
603
5920
Counselling and guidance which enhance independent living
R2130 [2001310196]
6.6e-01
9.9e-02
-1.0e+50
—
—
2.0e+00
1.8e+00
cases:5.07%
controls:2.70%
cases:1.39%
controls:1.26%
cases:0.00%
controls:0.21%
—
—
—
—
cases:6.65%
controls:0.97%
cases:7.73%
controls:1.41%
31
159
581
5740
9
78
640
6124
0
13
649
6189
—
—
43
60
604
6118
48
84
573
5863
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
-1.6e-01
2.6e-01
5.5e-01
1.8e+00
9.5e-01
4.5e-01
5.5e-01
cases:14.38%
controls:16.49%
cases:19.11%
controls:15.38%
cases:6.47%
controls:3.84%
cases:2.47%
controls:0.44%
cases:7.55%
controls:3.05%
cases:16.54%
controls:11.25%
cases:28.66%
controls:18.83%
88
973
524
4926
124
954
525
5248
42
238
607
5964
16
27
633
6175
49
189
600
6012
107
695
540
5483
178
1120
443
4827
budesonide; inhalant
R03BA02 [21603285]
8.8e-01
9.0e-01
—
—
5.0e-01
1.0e+00
8.7e-01
cases:8.17%
controls:3.54%
cases:4.31%
controls:1.81%
—
—
—
—
cases:0.77%
controls:0.47%
cases:4.17%
controls:1.51%
cases:7.25%
controls:3.18%
50
209
562
5690
28
112
621
6090
—
—
5
29
644
6172
27
93
620
6085
45
189
576
5758
Inpatient Hospital
21 [8717]
-1.5e-01
8.7e-02
3.3e-01
3.0e+00
5.9e-01
6.8e-01
1.0e-01
cases:28.59%
controls:31.65%
cases:13.41%
controls:12.43%
cases:2.62%
controls:1.90%
cases:2.16%
controls:0.11%
cases:2.62%
controls:1.47%
cases:16.23%
controls:8.90%
cases:21.42%
controls:19.77%
175
1867
437
4032
87
771
562
5431
17
118
632
6084
14
7
635
6195
17
91
632
6110
105
550
542
5628
133
1176
488
4771
Lutropin [Units/volume] in Serum or Plasma
10501-5 [3009214]
1.5e+00
1.4e+00
—
1.0e+50
—
2.1e+00
1.5e+00
cases:1.14%
controls:0.25%
cases:1.54%
controls:0.40%
—
—
cases:0.77%
controls:0.00%
—
—
cases:3.09%
controls:0.37%
cases:7.09%
controls:1.66%
7
15
605
5884
10
25
639
6177
—
5
0
644
6202
—
20
23
627
6155
44
99
577
5848
Inhibin B [Mass/volume] in Serum or Plasma
34319-4 [3045781]
—
—
—
—
—
2.1e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.15%
cases:2.42%
controls:0.59%
—
—
—
—
—
8
9
639
6169
15
35
606
5912
Delayed milestone
R62.0 [45597195]
5.6e-01
8.4e-01
2.3e+00
—
2.1e+00
1.0e+00
1.4e+00
cases:2.94%
controls:1.70%
cases:2.31%
controls:1.02%
cases:0.77%
controls:0.08%
—
—
cases:0.92%
controls:0.11%
cases:1.55%
controls:0.55%
cases:1.77%
controls:0.45%
18
100
594
5799
15
63
634
6139
5
5
644
6197
—
6
7
643
6194
10
34
637
6144
11
27
610
5920
FEV1
20150-9 [3024653]
3.9e-01
1.1e+00
—
—
—
1.4e+00
9.8e-01
cases:1.47%
controls:1.00%
cases:2.00%
controls:0.68%
—
—
—
—
—
—
cases:2.16%
controls:0.55%
cases:4.67%
controls:1.80%
9
59
603
5840
13
42
636
6160
—
—
—
14
34
633
6144
29
107
592
5840
FEV1/FVC
19926-5 [3011505]
3.9e-01
1.1e+00
—
—
—
1.4e+00
9.8e-01
cases:1.47%
controls:1.00%
cases:2.00%
controls:0.68%
—
—
—
—
—
—
cases:2.16%
controls:0.55%
cases:4.67%
controls:1.80%
9
59
603
5840
13
42
636
6160
—
—
—
14
34
633
6144
29
107
592
5840
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
3.9e-01
1.1e+00
—
—
—
1.4e+00
9.8e-01
cases:1.47%
controls:1.00%
cases:2.00%
controls:0.68%
—
—
—
—
—
—
cases:2.16%
controls:0.55%
cases:4.67%
controls:1.80%
9
59
603
5840
13
42
636
6160
—
—
—
14
34
633
6144
29
107
592
5840
Clinical Cytogenetics and Genomics
OMOP4822000 [32411]
1.5e-01
4.3e-01
-1.0e+50
1.0e+50
—
2.0e+00
1.3e+00
cases:3.92%
controls:3.39%
cases:2.31%
controls:1.52%
cases:0.00%
controls:0.11%
cases:1.08%
controls:0.00%
—
—
cases:4.33%
controls:0.60%
cases:5.15%
controls:1.41%
24
200
588
5699
15
94
634
6108
0
7
649
6195
7
0
642
6202
—
28
37
619
6141
32
84
589
5863
General evaluation of the need for rehabilitation
R1100 [2001310172]
4.8e-01
—
—
—
—
1.8e+00
1.5e+00
cases:1.96%
controls:1.22%
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.18%
cases:1.61%
controls:0.35%
12
72
600
5827
—
—
—
—
7
11
640
6167
10
21
611
5926
androstanolone
A14AA01 [21600917]
—
1.0e+50
—
—
—
—
3.3e+00
—
—
cases:0.77%
controls:0.00%
—
—
—
—
—
—
—
—
cases:2.25%
controls:0.08%
—
5
0
644
6202
—
—
—
—
14
5
607
5942
androstanolone
G03BB02 [21602513]
—
1.0e+50
—
—
—
—
3.3e+00
—
—
cases:0.77%
controls:0.00%
—
—
—
—
—
—
—
—
cases:2.25%
controls:0.08%
—
5
0
644
6202
—
—
—
—
14
5
607
5942
Testosterone [Moles/volume] in Serum or Plasma
14913-8 [3017446]
1.4e+00
1.1e+00
—
—
—
2.1e+00
1.2e+00
cases:1.14%
controls:0.29%
cases:0.77%
controls:0.26%
—
—
—
—
—
—
cases:2.01%
controls:0.26%
cases:4.67%
controls:1.40%
7
17
605
5882
5
16
644
6186
—
—
—
13
16
634
6162
29
83
592
5864
Case Management Agency
251B00000X [38004193]
7.5e-02
1.2e-01
-3.4e-03
3.0e+00
2.9e-01
3.0e-01
1.5e-01
cases:43.46%
controls:41.63%
cases:40.99%
controls:38.08%
cases:16.64%
controls:16.69%
cases:13.10%
controls:0.76%
cases:21.11%
controls:16.72%
cases:48.38%
controls:41.10%
cases:57.00%
controls:53.20%
266
2456
346
3443
266
2362
383
3840
108
1035
541
5167
85
47
564
6155
137
1037
512
5164
313
2539
334
3639
354
3164
267
2783
Scheduled procedure
ZXD10 [2001311387]
2.1e-01
4.4e-01
1.1e+00
—
—
1.7e+00
1.6e+00
cases:10.62%
controls:8.78%
cases:6.32%
controls:4.14%
cases:1.23%
controls:0.40%
—
—
—
—
cases:7.26%
controls:1.46%
cases:8.05%
controls:1.82%
65
518
547
5381
41
257
608
5945
8
25
641
6177
—
—
47
90
600
6088
50
108
571
5839
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
8.1e-01
1.4e+00
—
—
—
1.3e+00
1.7e+00
cases:1.96%
controls:0.88%
cases:1.69%
controls:0.42%
—
—
—
—
—
—
cases:1.24%
controls:0.32%
cases:3.38%
controls:0.62%
12
52
600
5847
11
26
638
6176
—
—
—
8
20
639
6158
21
37
600
5910
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]
—
1.0e+50
—
—
—
—
3.1e+00
—
—
cases:0.77%
controls:0.00%
—
—
—
—
—
—
—
—
cases:2.25%
controls:0.10%
—
5
0
644
6202
—
—
—
—
14
6
607
5941
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-2.6e-01
2.5e-01
4.3e-01
1.7e+00
9.0e-01
2.9e-01
4.9e-01
cases:13.73%
controls:17.05%
cases:19.11%
controls:15.53%
cases:5.86%
controls:3.89%
cases:2.47%
controls:0.47%
cases:7.09%
controls:3.02%
cases:14.84%
controls:11.54%
cases:27.86%
controls:19.17%
84
1006
528
4893
124
963
525
5239
38
241
611
5961
16
29
633
6173
46
187
603
6014
96
713
551
5465
173
1140
448
4807
alfacalcidol; oral, parenteral
A11CC03 [21600818]
1.6e+00
7.1e-01
—
—
—
1.4e+00
1.1e+00
cases:2.61%
controls:0.53%
cases:1.23%
controls:0.61%
—
—
—
—
—
—
cases:1.55%
controls:0.37%
cases:1.45%
controls:0.47%
16
31
596
5868
8
38
641
6164
—
—
—
10
23
637
6155
9
28
612
5919
Nutritional therapy
R4190 [2001310243]
8.0e-01
3.1e-01
9.2e-01
—
1.4e+00
9.5e-01
7.2e-01
cases:3.59%
controls:1.64%
cases:2.93%
controls:2.16%
cases:0.92%
controls:0.37%
—
—
cases:1.54%
controls:0.39%
cases:4.95%
controls:1.97%
cases:4.99%
controls:2.51%
22
97
590
5802
19
134
630
6068
6
23
643
6179
—
10
24
639
6177
32
122
615
6056
31
149
590
5798
Social worker
Z2446 [2001311559]
3.3e-01
-2.4e-01
—
—
—
1.2e+00
1.7e+00
cases:6.05%
controls:4.44%
cases:1.23%
controls:1.56%
—
—
—
—
—
—
cases:2.32%
controls:0.70%
cases:3.38%
controls:0.61%
37
262
575
5637
8
97
641
6105
—
—
—
15
43
632
6135
21
36
600
5911
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
-1.8e-01
2.4e-01
5.4e-01
1.7e+00
8.6e-01
3.0e-01
3.6e-01
cases:15.36%
controls:17.85%
cases:20.34%
controls:16.66%
cases:6.93%
controls:4.14%
cases:2.62%
controls:0.47%
cases:7.86%
controls:3.48%
cases:16.85%
controls:13.03%
cases:30.27%
controls:23.26%
94
1053
518
4846
132
1033
517
5169
45
257
604
5945
17
29
632
6173
51
216
598
5985
109
805
538
5373
188
1383
433
4564
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
-1.7e-01
2.4e-01
5.4e-01
1.7e+00
8.6e-01
3.0e-01
3.6e-01
cases:15.52%
controls:17.87%
cases:20.34%
controls:16.66%
cases:6.93%
controls:4.16%
cases:2.62%
controls:0.47%
cases:7.86%
controls:3.50%
cases:16.85%
controls:13.09%
cases:30.43%
controls:23.32%
95
1054
517
4845
132
1033
517
5169
45
258
604
5944
17
29
632
6173
51
217
598
5984
109
809
538
5369
189
1387
432
4560
Platelets [#/volume] in Blood
26515-7 [3007461]
-1.8e-01
2.4e-01
5.4e-01
1.7e+00
8.6e-01
3.0e-01
3.6e-01
cases:15.36%
controls:17.85%
cases:20.34%
controls:16.66%
cases:6.93%
controls:4.14%
cases:2.62%
controls:0.47%
cases:7.86%
controls:3.48%
cases:16.85%
controls:13.05%
cases:30.27%
controls:23.27%
94
1053
518
4846
132
1033
517
5169
45
257
604
5945
17
29
632
6173
51
216
598
5985
109
806
538
5372
188
1384
433
4563
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
-1.8e-01
2.4e-01
5.4e-01
1.7e+00
8.6e-01
3.0e-01
3.6e-01
cases:15.36%
controls:17.85%
cases:20.34%
controls:16.66%
cases:6.93%
controls:4.14%
cases:2.62%
controls:0.47%
cases:7.86%
controls:3.48%
cases:16.85%
controls:13.06%
cases:30.27%
controls:23.32%
94
1053
518
4846
132
1033
517
5169
45
257
604
5945
17
29
632
6173
51
216
598
5985
109
807
538
5371
188
1387
433
4560
MCH [Entitic mass]
28539-5 [3035941]
-1.8e-01
2.5e-01
5.4e-01
1.7e+00
8.6e-01
3.0e-01
3.6e-01
cases:15.36%
controls:17.85%
cases:20.34%
controls:16.64%
cases:6.93%
controls:4.14%
cases:2.62%
controls:0.47%
cases:7.86%
controls:3.48%
cases:16.85%
controls:13.06%
cases:30.27%
controls:23.32%
94
1053
518
4846
132
1032
517
5170
45
257
604
5945
17
29
632
6173
51
216
598
5985
109
807
538
5371
188
1387
433
4560
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
-1.8e-01
2.5e-01
5.4e-01
1.7e+00
8.6e-01
3.0e-01
3.5e-01
cases:15.36%
controls:17.85%
cases:20.34%
controls:16.64%
cases:6.93%
controls:4.14%
cases:2.62%
controls:0.47%
cases:7.86%
controls:3.48%
cases:16.85%
controls:13.06%
cases:30.27%
controls:23.36%
94
1053
518
4846
132
1032
517
5170
45
257
604
5945
17
29
632
6173
51
216
598
5985
109
807
538
5371
188
1389
433
4558
Leukocytes [#/volume] in Blood
26464-8 [3010813]
-1.6e-01
2.4e-01
5.4e-01
1.7e+00
8.6e-01
2.9e-01
3.5e-01
cases:15.69%
controls:17.94%
cases:20.34%
controls:16.69%
cases:6.93%
controls:4.14%
cases:2.62%
controls:0.47%
cases:7.86%
controls:3.48%
cases:16.85%
controls:13.21%
cases:30.43%
controls:23.52%
96
1058
516
4841
132
1035
517
5167
45
257
604
5945
17
29
632
6173
51
216
598
5985
109
816
538
5362
189
1399
432
4548
Disturbance of activity and attention
F90.0 [45542870]
8.1e-01
1.2e+00
8.3e-01
—
1.7e+00
8.5e-01
5.8e-01
cases:2.29%
controls:1.03%
cases:2.47%
controls:0.74%
cases:0.77%
controls:0.34%
—
—
cases:1.23%
controls:0.23%
cases:2.32%
controls:1.00%
cases:5.48%
controls:3.13%
14
61
598
5838
16
46
633
6156
5
21
644
6181
—
8
14
641
6187
15
62
632
6116
34
186
587
5761
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
4.1e-01
2.0e-01
-1.0e+50
—
—
1.5e+00
1.4e+00
cases:3.10%
controls:2.09%
cases:0.92%
controls:0.76%
cases:0.00%
controls:0.08%
—
—
—
—
cases:1.55%
controls:0.36%
cases:2.42%
controls:0.61%
19
123
593
5776
6
47
643
6155
0
5
649
6197
—
—
10
22
637
6156
15
36
606
5911
Supplier / Service Provider
OMOP5117446 [33004]
-8.8e-01
-1.0e+00
-3.8e-01
—
—
2.6e+00
2.1e+00
cases:7.19%
controls:15.70%
cases:4.01%
controls:10.16%
cases:1.08%
controls:1.56%
—
—
—
—
cases:6.65%
controls:0.55%
cases:12.88%
controls:1.80%
44
926
568
4973
26
630
623
5572
7
97
642
6105
—
—
43
34
604
6144
80
107
541
5840
Specific developmental disorder of motor function
F82 [45605516]
5.9e-01
1.1e+00
-1.0e+50
—
—
1.4e+00
1.3e+00
cases:1.31%
controls:0.73%
cases:1.23%
controls:0.40%
cases:0.00%
controls:0.08%
—
—
—
—
cases:1.55%
controls:0.37%
cases:2.42%
controls:0.66%
8
43
604
5856
8
25
641
6177
0
5
649
6197
—
—
10
23
637
6155
15
39
606
5908
tacrolimus; oral, parenteral
L04AD02 [21603925]
1.5e+00
1.2e+00
—
—
1.6e+00
1.2e+00
5.6e-01
cases:1.96%
controls:0.44%
cases:1.85%
controls:0.55%
—
—
—
—
cases:0.92%
controls:0.19%
cases:1.85%
controls:0.58%
cases:1.29%
controls:0.74%
12
26
600
5873
12
34
637
6168
—
—
6
12
643
6189
12
36
635
6142
8
44
613
5903
TREATMENT - Kidney transplant
TREATMENT-51 [2002330239]
2.6e+00
—
—
—
—
—
—
cases:1.63%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
10
7
602
5892
—
—
—
—
—
—
erythropoietin; parenteral
B03XA01 [21601133]
2.6e+00
—
—
—
—
—
—
cases:1.14%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
7
5
605
5894
—
—
—
—
—
—
Office Visit
OMOP4822458 [581477]
-1.2e-01
-4.6e-02
-3.9e-01
2.6e+00
8.2e-01
2.5e-01
-2.1e-01
cases:13.24%
controls:14.61%
cases:8.78%
controls:9.16%
cases:0.92%
controls:1.35%
cases:1.08%
controls:0.08%
cases:2.47%
controls:1.10%
cases:10.82%
controls:8.64%
cases:13.04%
controls:15.55%
81
862
531
5037
57
568
592
5634
6
84
643
6118
7
5
642
6197
16
68
633
6133
70
534
577
5644
81
925
540
5022
hydrocortisone; oral, parenteral
H02AB09 [21602737]
7.7e-01
8.7e-01
—
—
2.1e+00
1.0e+00
7.8e-01
cases:5.88%
controls:2.81%
cases:2.16%
controls:0.92%
—
—
—
—
cases:0.77%
controls:0.10%
cases:2.78%
controls:1.04%
cases:4.83%
controls:2.27%
36
166
576
5733
14
57
635
6145
—
—
5
6
644
6195
18
64
629
6114
30
135
591
5812
One hour or less
ZXE00 [2001311394]
2.8e-02
3.7e-01
6.9e-01
—
—
1.5e+00
1.0e+00
cases:12.09%
controls:11.80%
cases:6.63%
controls:4.66%
cases:0.92%
controls:0.47%
—
—
—
—
cases:7.26%
controls:1.68%
cases:9.02%
controls:3.53%
74
696
538
5203
43
289
606
5913
6
29
643
6173
—
—
47
104
600
6074
56
210
565
5737
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
6.7e-01
7.8e-01
-1.0e+50
—
-1.0e+50
1.4e+00
1.1e+00
cases:3.92%
controls:2.05%
cases:2.47%
controls:1.14%
cases:0.00%
controls:0.08%
—
—
cases:0.00%
controls:0.10%
cases:2.63%
controls:0.65%
cases:4.67%
controls:1.61%
24
121
588
5778
16
71
633
6131
0
5
649
6197
—
0
6
649
6195
17
40
630
6138
29
96
592
5851
CBC panel - Blood by Automated count
58410-2 [40761511]
-8.0e-02
-7.3e-02
3.6e-01
2.5e+00
6.4e-01
3.8e-01
3.6e-01
cases:12.25%
controls:13.14%
cases:9.86%
controls:10.53%
cases:2.93%
controls:2.06%
cases:1.54%
controls:0.13%
cases:2.77%
controls:1.48%
cases:10.05%
controls:7.07%
cases:18.36%
controls:13.55%
75
775
537
5124
64
653
585
5549
19
128
630
6074
10
8
639
6194
18
92
631
6109
65
437
582
5741
114
806
507
5141
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
8.4e-01
2.5e+00
—
—
—
-1.0e+50
3.4e-01
cases:0.82%
controls:0.36%
cases:1.54%
controls:0.13%
—
—
—
—
—
—
cases:0.00%
controls:0.21%
cases:0.81%
controls:0.57%
5
21
607
5878
10
8
639
6194
—
—
—
0
13
647
6165
5
34
616
5913
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
-3.1e-01
1.8e-01
1.5e+00
—
—
9.1e-01
2.5e+00
cases:1.14%
controls:1.56%
cases:1.23%
controls:1.03%
cases:0.77%
controls:0.18%
—
—
—
—
cases:1.39%
controls:0.57%
cases:2.90%
controls:0.25%
7
92
605
5807
8
64
641
6138
5
11
644
6191
—
—
9
35
638
6143
18
15
603
5932
bacitracin; ointment
D06AX05 [21602065]
—
-1.0e+50
—
—
—
-1.0e+50
2.4e+00
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.97%
controls:0.08%
—
0
6
649
6196
—
—
—
0
5
647
6173
6
5
615
5942
neomycin; ointment
D06AX04 [21602064]
—
-1.0e+50
—
—
—
-1.0e+50
2.4e+00
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.97%
controls:0.08%
—
0
6
649
6196
—
—
—
0
5
647
6173
6
5
615
5942
Amino acids [Identifier] in Serum or Plasma
12468-5 [3013336]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.08%
—
—
—
—
—
—
6
5
615
5942
Genetic counselling
Z31.5 [45590715]
-3.7e-01
-3.7e-01
—
—
-1.0e+50
1.4e+00
9.9e-01
cases:1.63%
controls:2.34%
cases:0.77%
controls:1.11%
—
—
—
—
cases:0.00%
controls:0.13%
cases:2.32%
controls:0.57%
cases:3.06%
controls:1.16%
10
138
602
5761
5
69
644
6133
—
—
0
8
649
6193
15
35
632
6143
19
69
602
5878
Diastolic blood pressure
8462-4 [3012888]
2.4e+00
—
—
—
—
—
-1.0e+50
cases:1.31%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
8
7
604
5892
—
—
—
—
—
0
5
621
5942
Systolic blood pressure
8480-6 [3004249]
2.4e+00
—
—
—
—
—
-1.0e+50
cases:1.31%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
8
7
604
5892
—
—
—
—
—
0
5
621
5942
beclometasone; inhalant
R03BA01 [21603284]
1.1e+00
2.4e+00
—
—
—
—
—
cases:0.98%
controls:0.34%
cases:1.23%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
6
20
606
5879
8
7
641
6195
—
—
—
—
—
Cystoscopy
UKC02 [2001306005]
9.6e-01
—
—
—
—
-1.0e+50
2.4e+00
cases:1.14%
controls:0.44%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
cases:1.61%
controls:0.15%
7
26
605
5873
—
—
—
—
0
11
647
6167
10
9
611
5938
Chronic disorders of vitamin D metabolism
123 [2001600122]
2.3e+00
—
—
—
—
—
—
cases:1.14%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
7
7
605
5892
—
—
—
—
—
—
Procedure duration 10 to 19 minutes
ZXE02 [2001311396]
2.7e-01
1.2e+00
—
—
—
—
2.3e+00
cases:0.82%
controls:0.63%
cases:0.77%
controls:0.23%
—
—
—
—
—
—
—
—
cases:1.29%
controls:0.13%
5
37
607
5862
5
14
644
6188
—
—
—
—
8
8
613
5939
Tissue transglutaminase IgG Ab [Units/volume] in Serum
32998-7 [3046870]
7.6e-01
1.5e+00
—
—
—
1.2e+00
7.4e-01
cases:1.47%
controls:0.70%
cases:1.69%
controls:0.37%
—
—
—
—
—
—
cases:1.24%
controls:0.37%
cases:4.99%
controls:2.46%
9
41
603
5858
11
23
638
6179
—
—
—
8
23
639
6155
31
146
590
5801
Elastase.pancreatic [Mass/mass] in Stool
25907-7 [3000570]
—
1.1e+00
—
—
—
2.3e+00
1.0e+00
—
—
cases:0.92%
controls:0.31%
—
—
—
—
—
—
cases:1.08%
controls:0.11%
cases:0.81%
controls:0.29%
—
6
19
643
6183
—
—
—
7
7
640
6171
5
17
616
5930
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
7.7e-01
—
—
—
—
2.3e+00
1.2e+00
cases:1.31%
controls:0.61%
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.11%
cases:0.97%
controls:0.30%
8
36
604
5863
—
—
—
—
7
7
640
6171
6
18
615
5929
FEV1 percent change
69983-5 [42868472]
3.9e-01
1.0e+00
—
—
—
1.3e+00
9.5e-01
cases:1.47%
controls:1.00%
cases:1.85%
controls:0.68%
—
—
—
—
—
—
cases:2.01%
controls:0.55%
cases:4.51%
controls:1.80%
9
59
603
5840
12
42
637
6160
—
—
—
13
34
634
6144
28
107
593
5840
FVC percent change Respiratory system
69982-7 [42868471]
3.9e-01
1.0e+00
—
—
—
1.3e+00
9.5e-01
cases:1.47%
controls:1.00%
cases:1.85%
controls:0.68%
—
—
—
—
—
—
cases:2.01%
controls:0.55%
cases:4.51%
controls:1.80%
9
59
603
5840
12
42
637
6160
—
—
—
13
34
634
6144
28
107
593
5840
FEV1/FVC --post bronchodilation
69970-2 [42868459]
3.9e-01
1.0e+00
—
—
—
1.3e+00
9.5e-01
cases:1.47%
controls:1.00%
cases:1.85%
controls:0.68%
—
—
—
—
—
—
cases:2.01%
controls:0.55%
cases:4.51%
controls:1.80%
9
59
603
5840
12
42
637
6160
—
—
—
13
34
634
6144
28
107
593
5840
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
3.9e-01
1.0e+00
—
—
—
1.3e+00
9.5e-01
cases:1.47%
controls:1.00%
cases:1.85%
controls:0.68%
—
—
—
—
—
—
cases:2.01%
controls:0.55%
cases:4.51%
controls:1.80%
9
59
603
5840
12
42
637
6160
—
—
—
13
34
634
6144
28
107
593
5840
FEV1 --post bronchodilation
20155-8 [3023550]
3.9e-01
1.0e+00
—
—
—
1.3e+00
9.5e-01
cases:1.47%
controls:1.00%
cases:1.85%
controls:0.68%
—
—
—
—
—
—
cases:2.01%
controls:0.55%
cases:4.51%
controls:1.80%
9
59
603
5840
12
42
637
6160
—
—
—
13
34
634
6144
28
107
593
5840
Paediatric neurology
421 [44777781]
5.2e-01
5.1e-01
2.1e-01
—
6.7e-01
6.8e-01
5.4e-01
cases:16.50%
controls:10.54%
cases:13.56%
controls:8.59%
cases:2.31%
controls:1.89%
—
—
cases:3.08%
controls:1.60%
cases:14.06%
controls:7.64%
cases:15.78%
controls:9.80%
101
622
511
5277
88
533
561
5669
15
117
634
6085
—
20
99
629
6102
91
472
556
5706
98
583
523
5364
Cathetrisation of vein
TPH04 [2001309597]
6.7e-01
7.2e-01
—
—
—
1.3e+00
9.0e-01
cases:3.76%
controls:1.95%
cases:1.54%
controls:0.76%
—
—
—
—
—
—
cases:2.16%
controls:0.58%
cases:3.22%
controls:1.33%
23
115
589
5784
10
47
639
6155
—
—
—
14
36
633
6142
20
79
601
5868
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
1.5e-01
5.2e-01
1.4e+00
—
1.2e+00
9.2e-01
1.3e+00
cases:3.27%
controls:2.83%
cases:3.70%
controls:2.23%
cases:1.39%
controls:0.35%
—
—
cases:1.08%
controls:0.32%
cases:6.34%
controls:2.62%
cases:18.68%
controls:6.05%
20
167
592
5732
24
138
625
6064
9
22
640
6180
—
7
20
642
6181
41
162
606
6016
116
360
505
5587
More than one and less than three hours
ZXE10 [2001311401]
2.9e-01
1.7e-01
1.2e+00
—
—
1.2e+00
9.4e-01
cases:8.99%
controls:6.90%
cases:3.24%
controls:2.74%
cases:0.77%
controls:0.24%
—
—
—
—
cases:3.55%
controls:1.07%
cases:5.64%
controls:2.27%
55
407
557
5492
21
170
628
6032
5
15
644
6187
—
—
23
66
624
6112
35
135
586
5812
Transplant complication
127 [2001600125]
2.2e+00
—
—
—
—
—
—
cases:2.61%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
—
16
18
596
5881
—
—
—
—
—
—
Chronic asthma and similar chronic obstructive pulmonary diseases
203 [2001600201]
1.0e+00
5.5e-01
—
—
-1.0e+50
1.1e+00
3.7e-01
cases:9.31%
controls:3.59%
cases:1.39%
controls:0.81%
—
—
—
—
cases:0.00%
controls:0.10%
cases:2.32%
controls:0.76%
cases:2.90%
controls:2.02%
57
212
555
5687
9
50
640
6152
—
—
0
6
649
6195
15
47
632
6131
18
120
603
5827
Nephrectomy
KAC00 [2001305666]
2.1e+00
—
—
—
—
—
—
cases:1.14%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
7
8
605
5891
—
—
—
—
—
—
Severe anaemia associated with chronic renal failure
138 [2001600134]
2.1e+00
—
—
—
—
—
—
cases:0.98%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
606
5892
—
—
—
—
—
—
Intravenous general anesthesia
WX404 [2001310807]
7.9e-02
-3.4e-01
—
—
—
1.1e+00
1.0e+00
cases:8.33%
controls:7.75%
cases:2.77%
controls:3.85%
—
—
—
—
—
—
cases:5.56%
controls:1.91%
cases:4.99%
controls:1.88%
51
457
561
5442
18
239
631
5963
—
—
—
36
118
611
6060
31
112
590
5835
Coloscopy
UJF32 [2001305029]
9.9e-01
1.2e+00
—
—
—
2.1e+00
7.7e-01
cases:1.80%
controls:0.68%
cases:1.08%
controls:0.34%
—
—
—
—
—
—
cases:0.93%
controls:0.11%
cases:1.93%
controls:0.91%
11
40
601
5859
7
21
642
6181
—
—
—
6
7
641
6171
12
54
609
5893
Nonallergic asthma
J45.1 [45557625]
5.9e-01
6.1e-01
—
—
2.1e+00
6.9e-01
5.2e-01
cases:5.56%
controls:3.17%
cases:3.39%
controls:1.87%
—
—
—
—
cases:1.69%
controls:0.21%
cases:3.86%
controls:1.97%
cases:4.51%
controls:2.74%
34
187
578
5712
22
116
627
6086
—
—
11
13
638
6188
25
122
622
6056
28
163
593
5784
filgrastim; parenteral
L03AA02 [21603851]
2.1e+00
—
—
—
—
—
—
cases:1.31%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
—
—
8
10
604
5889
—
—
—
—
—
—
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
3.2e-01
6.7e-01
1.2e+00
—
2.0e+00
7.6e-01
5.0e-01
cases:2.94%
controls:2.15%
cases:3.08%
controls:1.60%
cases:0.77%
controls:0.23%
—
—
cases:1.23%
controls:0.16%
cases:2.16%
controls:1.02%
cases:3.06%
controls:1.88%
18
127
594
5772
20
99
629
6103
5
14
644
6188
—
8
10
641
6191
14
63
633
6115
19
112
602
5835
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
14688-6 [3016616]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.77%
controls:0.24%
—
—
—
—
—
—
11
14
610
5933
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
2.1e-01
8.8e-01
8.7e-01
—
1.1e+00
4.4e-01
2.4e-01
cases:8.99%
controls:7.41%
cases:12.48%
controls:5.58%
cases:2.31%
controls:0.98%
—
—
cases:3.24%
controls:1.05%
cases:6.80%
controls:4.50%
cases:10.95%
controls:8.83%
55
437
557
5462
81
346
568
5856
15
61
634
6141
—
21
65
628
6136
44
278
603
5900
68
525
553
5422
CICLOSPORIN - yes
CICLOSPORIN-1 [2002330221]
2.0e+00
—
—
—
—
—
—
cases:1.14%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
7
9
605
5890
—
—
—
—
—
—
High dependency care
WX882 [2001310847]
3.1e-01
—
-1.0e+50
—
—
1.7e+00
2.0e+00
cases:3.76%
controls:2.80%
—
—
cases:0.00%
controls:0.10%
—
—
—
—
cases:0.77%
controls:0.15%
cases:1.13%
controls:0.15%
23
165
589
5734
—
0
6
649
6196
—
—
5
9
642
6169
7
9
614
5938
montelukast; oral
R03DC03 [21603356]
4.6e-01
6.4e-01
—
—
8.1e-01
1.1e+00
8.9e-01
cases:4.74%
controls:3.03%
cases:3.39%
controls:1.82%
—
—
—
—
cases:1.08%
controls:0.48%
cases:4.95%
controls:1.67%
cases:6.60%
controls:2.82%
29
179
583
5720
22
113
627
6089
—
—
7
30
642
6171
32
103
615
6075
41
168
580
5779
Normoblasts [#/volume] in Blood
715-3 [3021589]
1.1e-03
2.7e-01
6.0e-01
1.7e+00
8.6e-01
5.6e-01
5.9e-01
cases:8.82%
controls:8.82%
cases:9.86%
controls:7.67%
cases:3.54%
controls:1.97%
cases:1.08%
controls:0.19%
cases:4.31%
controls:1.87%
cases:9.74%
controls:5.81%
cases:17.55%
controls:10.58%
54
520
558
5379
64
476
585
5726
23
122
626
6080
7
12
642
6190
28
116
621
6085
63
359
584
5819
109
629
512
5318
Sleep apnoea
G47.3 [45562094]
1.6e+00
—
—
—
—
—
2.0e+00
cases:0.82%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:1.45%
controls:0.20%
5
10
607
5889
—
—
—
—
—
9
12
612
5935
Psychologist
Z2445 [2001311558]
6.7e-01
6.9e-01
—
—
—
7.8e-01
2.0e+00
cases:4.90%
controls:2.56%
cases:1.85%
controls:0.94%
—
—
—
—
—
—
cases:1.55%
controls:0.71%
cases:4.35%
controls:0.62%
30
151
582
5748
12
58
637
6144
—
—
—
10
44
637
6134
27
37
594
5910
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
-4.4e-02
2.8e-01
6.0e-01
1.7e+00
9.1e-01
5.1e-01
5.7e-01
cases:9.15%
controls:9.53%
cases:10.02%
controls:7.76%
cases:3.54%
controls:1.98%
cases:0.92%
controls:0.18%
cases:4.62%
controls:1.92%
cases:9.74%
controls:6.10%
cases:18.36%
controls:11.30%
56
562
556
5337
65
481
584
5721
23
123
626
6079
6
11
643
6191
30
119
619
6082
63
377
584
5801
114
672
507
5275
Basophils/Leukocytes in Blood
30180-4 [3022096]
-9.7e-02
3.0e-01
6.0e-01
1.7e+00
8.8e-01
4.9e-01
6.1e-01
cases:8.66%
controls:9.46%
cases:10.17%
controls:7.76%
cases:3.54%
controls:1.97%
cases:0.92%
controls:0.18%
cases:4.62%
controls:1.97%
cases:9.58%
controls:6.09%
cases:18.52%
controls:11.01%
53
558
559
5341
66
481
583
5721
23
122
626
6080
6
11
643
6191
30
122
619
6079
62
376
585
5802
115
655
506
5292
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
-9.9e-02
3.0e-01
5.5e-01
1.7e+00
8.7e-01
4.9e-01
6.1e-01
cases:8.66%
controls:9.48%
cases:10.17%
controls:7.76%
cases:3.39%
controls:1.98%
cases:0.92%
controls:0.18%
cases:4.62%
controls:1.98%
cases:9.58%
controls:6.09%
cases:18.52%
controls:11.01%
53
559
559
5340
66
481
583
5721
22
123
627
6079
6
11
643
6191
30
123
619
6078
62
376
585
5802
115
655
506
5292
Monocytes/Leukocytes in Blood
26485-3 [3019069]
-6.2e-02
3.1e-01
6.0e-01
1.7e+00
8.7e-01
4.9e-01
6.0e-01
cases:8.99%
controls:9.51%
cases:10.32%
controls:7.76%
cases:3.54%
controls:1.98%
cases:0.92%
controls:0.18%
cases:4.62%
controls:1.98%
cases:9.58%
controls:6.09%
cases:18.52%
controls:11.05%
55
561
557
5338
67
481
582
5721
23
123
626
6079
6
11
643
6191
30
123
619
6078
62
376
585
5802
115
657
506
5290
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
4.1e-01
7.0e-01
8.3e-01
—
1.3e+00
4.1e-01
4.9e-01
cases:6.37%
controls:4.31%
cases:6.78%
controls:3.50%
cases:2.00%
controls:0.89%
—
—
cases:2.93%
controls:0.84%
cases:4.64%
controls:3.12%
cases:7.73%
controls:4.88%
39
254
573
5645
44
217
605
5985
13
55
636
6147
—
19
52
630
6149
30
193
617
5985
48
290
573
5657
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
2.0e+00
—
—
—
—
—
2.1e-01
cases:1.31%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.66%
8
11
604
5888
—
—
—
—
—
5
39
616
5908
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
-7.2e-02
2.2e-01
5.1e-01
1.4e+00
8.5e-01
5.0e-01
6.0e-01
cases:9.15%
controls:9.76%
cases:9.86%
controls:8.06%
cases:3.54%
controls:2.16%
cases:0.92%
controls:0.23%
cases:4.62%
controls:2.03%
cases:9.89%
controls:6.25%
cases:18.68%
controls:11.20%
56
576
556
5323
64
500
585
5702
23
134
626
6068
6
14
643
6188
30
126
619
6075
64
386
583
5792
116
666
505
5281
terbutaline; inhalant
R03AC03 [21603257]
9.7e-01
1.0e+00
—
—
—
8.8e-01
9.6e-01
cases:4.41%
controls:1.71%
cases:2.16%
controls:0.81%
—
—
—
—
—
—
cases:1.39%
controls:0.58%
cases:3.22%
controls:1.26%
27
101
585
5798
14
50
635
6152
—
—
—
9
36
638
6142
20
75
601
5872
Basophils [#/volume] in Blood
26444-0 [3006315]
-1.0e-01
2.7e-01
5.9e-01
1.8e+00
8.5e-01
4.8e-01
5.9e-01
cases:8.66%
controls:9.49%
cases:10.02%
controls:7.80%
cases:3.54%
controls:2.00%
cases:0.92%
controls:0.16%
cases:4.47%
controls:1.97%
cases:9.58%
controls:6.15%
cases:18.52%
controls:11.15%
53
560
559
5339
65
484
584
5718
23
124
626
6078
6
10
643
6192
29
122
620
6079
62
380
585
5798
115
663
506
5284
Other developmental disorders of scholastic skills
F81.8 [45542868]
1.9e+00
—
—
—
—
1.4e+00
1.1e+00
cases:1.14%
controls:0.17%
—
—
—
—
—
—
—
—
cases:0.77%
controls:0.19%
cases:0.97%
controls:0.32%
7
10
605
5889
—
—
—
—
5
12
642
6166
6
19
615
5928
AZATHIOPRINE - yes
AZATHIOPRINE-1 [2002330220]
1.9e+00
1.4e+00
—
—
—
1.0e+00
1.0e+00
cases:1.47%
controls:0.22%
cases:1.08%
controls:0.27%
—
—
—
—
—
—
cases:0.77%
controls:0.28%
cases:0.97%
controls:0.35%
9
13
603
5886
7
17
642
6185
—
—
—
5
17
642
6161
6
21
615
5926
Bloodpressure monitoring
XF602 [2001303378]
1.9e+00
—
—
—
—
—
1.6e+00
cases:1.47%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.20%
9
13
603
5886
—
—
—
—
—
6
12
615
5935
Hypothyroidism, unspecified
E03.9 [45537945]
—
—
—
—
—
1.9e+00
7.4e-01
—
—
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.16%
cases:0.81%
controls:0.39%
—
—
—
—
—
7
10
640
6168
5
23
616
5924
More than three and less than five hours
ZXE20 [2001311408]
4.9e-01
-4.6e-02
—
—
—
—
1.9e+00
cases:3.59%
controls:2.24%
cases:0.92%
controls:0.97%
—
—
—
—
—
—
—
—
cases:2.74%
controls:0.42%
22
132
590
5767
6
60
643
6142
—
—
—
—
17
25
604
5922
Other healthcare associate professional
Z3229 [2001311561]
3.2e-01
1.5e-01
-1.0e+50
—
—
5.0e-01
1.9e+00
cases:4.41%
controls:3.24%
cases:1.23%
controls:1.06%
cases:0.00%
controls:0.15%
—
—
—
—
cases:0.77%
controls:0.47%
cases:3.54%
controls:0.55%
27
191
585
5708
8
66
641
6136
0
9
649
6193
—
—
5
29
642
6149
22
33
599
5914
Eosinophils [#/volume] in Blood
26449-9 [3013115]
-1.0e-01
2.5e-01
5.6e-01
1.6e+00
8.2e-01
4.9e-01
5.6e-01
cases:8.82%
controls:9.70%
cases:10.17%
controls:8.09%
cases:3.54%
controls:2.05%
cases:0.92%
controls:0.19%
cases:4.47%
controls:2.02%
cases:9.89%
controls:6.28%
cases:19.00%
controls:11.77%
54
572
558
5327
66
502
583
5700
23
127
626
6075
6
12
643
6190
29
125
620
6076
64
388
583
5790
118
700
503
5247
Thorax X-ray examination
GD1AA [2001303617]
6.3e-02
1.6e-01
—
—
—
9.9e-01
8.9e-01
cases:5.72%
controls:5.39%
cases:3.24%
controls:2.77%
—
—
—
—
—
—
cases:2.94%
controls:1.12%
cases:7.09%
controls:3.03%
35
318
577
5581
21
172
628
6030
—
—
—
19
69
628
6109
44
180
577
5767
magnesium hydroxide; oral
G04BX01 [21602658]
1.2e+00
—
—
—
—
—
1.9e+00
cases:0.82%
controls:0.24%
—
—
—
—
—
—
—
—
—
—
cases:1.29%
controls:0.20%
5
14
607
5885
—
—
—
—
—
8
12
613
5935
magnesium hydroxide; oral
A02AA04 [21600052]
1.2e+00
—
—
—
—
—
1.9e+00
cases:0.82%
controls:0.24%
—
—
—
—
—
—
—
—
—
—
cases:1.29%
controls:0.20%
5
14
607
5885
—
—
—
—
—
8
12
613
5935
Hospital outpatient
ZY010 [2001311599]
3.6e-01
2.0e-01
—
—
—
6.0e-01
1.9e+00
cases:2.29%
controls:1.61%
cases:1.23%
controls:1.02%
—
—
—
—
—
—
cases:1.08%
controls:0.60%
cases:3.06%
controls:0.49%
14
95
598
5804
8
63
641
6139
—
—
—
7
37
640
6141
19
29
602
5918
Allergic and dietetic gastroenteritis and colitis
K52.2 [45591595]
7.2e-01
1.1e+00
—
—
—
1.9e+00
1.2e+00
cases:1.80%
controls:0.88%
cases:0.92%
controls:0.32%
—
—
—
—
—
—
cases:1.24%
controls:0.19%
cases:1.29%
controls:0.40%
11
52
601
5847
6
20
643
6182
—
—
—
8
12
639
6166
8
24
613
5923
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
2.5e-01
2.0e-01
8.8e-01
—
1.0e+00
4.2e-01
1.8e+00
cases:3.43%
controls:2.70%
cases:2.47%
controls:2.03%
cases:0.92%
controls:0.39%
—
—
cases:0.92%
controls:0.34%
cases:1.55%
controls:1.02%
cases:3.22%
controls:0.52%
21
159
591
5740
16
126
633
6076
6
24
643
6178
—
6
21
643
6180
10
63
637
6115
20
31
601
5916
lactulose; oral
A06AD11 [21600571]
3.4e-01
—
—
—
—
—
1.8e+00
cases:1.47%
controls:1.05%
—
—
—
—
—
—
—
—
—
—
cases:1.13%
controls:0.18%
9
62
603
5837
—
—
—
—
—
7
11
614
5936
Stomach Pathology biopsy report
66114-0 [40768797]
1.0e+00
8.2e-01
—
—
—
1.8e+00
6.3e-01
cases:1.47%
controls:0.53%
cases:1.39%
controls:0.61%
—
—
—
—
—
—
cases:1.08%
controls:0.18%
cases:1.45%
controls:0.77%
9
31
603
5868
9
38
640
6164
—
—
—
7
11
640
6167
9
46
612
5901
Spirometry for bronchospasm with prolonged evaluation after bronchodilator
113016006 [4010399]
5.5e-01
9.8e-01
—
—
—
6.2e-01
8.2e-01
cases:2.94%
controls:1.71%
cases:2.62%
controls:1.00%
—
—
—
—
—
—
cases:1.70%
controls:0.92%
cases:4.67%
controls:2.10%
18
101
594
5798
17
62
632
6140
—
—
—
11
57
636
6121
29
125
592
5822
Monitored bed care
WX892 [2001310850]
-5.6e-01
—
—
—
—
—
1.8e+00
cases:0.82%
controls:1.42%
—
—
—
—
—
—
—
—
—
—
cases:1.61%
controls:0.27%
5
84
607
5815
—
—
—
—
—
10
16
611
5931
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
4.1e-01
—
—
—
—
2.0e+00
1.8e+00
cases:0.82%
controls:0.54%
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.13%
cases:1.61%
controls:0.27%
5
32
607
5867
—
—
—
—
6
8
641
6170
10
16
611
5931
More than five and less than seven hours
ZXE30 [2001311411]
4.8e-01
—
—
—
—
-1.0e+50
1.8e+00
cases:1.80%
controls:1.12%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
cases:1.29%
controls:0.22%
11
66
601
5833
—
—
—
—
0
16
647
6162
8
13
613
5934
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
8.1e-01
1.2e+00
-1.0e+50
—
—
1.8e+00
1.1e+00
cases:1.96%
controls:0.88%
cases:1.54%
controls:0.45%
cases:0.00%
controls:0.15%
—
—
—
—
cases:1.39%
controls:0.24%
cases:1.45%
controls:0.47%
12
52
600
5847
10
28
639
6174
0
9
649
6193
—
—
9
15
638
6163
9
28
612
5919
Chronic mucoid otitis media
H65.3 [45567124]
7.1e-01
1.7e-01
-1.0e+50
—
—
5.2e-01
1.0e+00
cases:4.90%
controls:2.47%
cases:1.39%
controls:1.18%
cases:0.00%
controls:0.19%
—
—
—
—
cases:1.55%
controls:0.92%
cases:3.22%
controls:1.18%
30
146
582
5753
9
73
640
6129
0
12
649
6190
—
—
10
57
637
6121
20
70
601
5877
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 [3024403]
8.8e-02
—
-1.0e+50
—
-1.0e+50
—
1.7e+00
cases:0.98%
controls:0.90%
—
—
cases:0.00%
controls:0.08%
—
—
cases:0.00%
controls:0.10%
—
—
cases:1.29%
controls:0.24%
6
53
606
5846
—
0
5
649
6197
—
0
6
649
6195
—
8
14
613
5933
Other general examinations
Z00.8 [45581001]
—
1.7e+00
—
—
—
—
2.6e-01
—
—
cases:1.23%
controls:0.23%
—
—
—
—
—
—
—
—
cases:1.13%
controls:0.87%
—
8
14
641
6188
—
—
—
—
7
52
614
5895
ciclosporin; oral, parenteral
L04AD01 [21603924]
1.7e+00
1.2e+00
—
—
1.0e+00
1.1e+00
9.1e-01
cases:3.27%
controls:0.63%
cases:1.54%
controls:0.45%
—
—
—
—
cases:0.77%
controls:0.27%
cases:1.55%
controls:0.53%
cases:1.61%
controls:0.66%
20
37
592
5862
10
28
639
6174
—
—
5
17
644
6184
10
33
637
6145
10
39
611
5908
General anesthesia, balanced
WX408 [2001310808]
1.1e-01
4.6e-01
6.1e-01
—
—
8.2e-01
8.5e-01
cases:8.99%
controls:8.10%
cases:4.78%
controls:3.06%
cases:0.77%
controls:0.42%
—
—
—
—
cases:3.86%
controls:1.73%
cases:7.25%
controls:3.25%
55
478
557
5421
31
190
618
6012
5
26
644
6176
—
—
25
107
622
6071
45
193
576
5754
Dry eye syndrome
H04.10 [2000502254]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.29%
controls:0.25%
—
—
—
—
—
—
8
15
613
5932
Ultrasound examination transplanted kidney
KA2AE [2001305644]
1.5e+00
1.6e+00
—
—
—
1.9e+00
—
cases:1.31%
controls:0.29%
cases:1.23%
controls:0.24%
—
—
—
—
—
—
cases:0.93%
controls:0.15%
—
—
8
17
604
5882
8
15
641
6187
—
—
—
6
9
641
6169
—
Day surgery
ZXD20 [2001311388]
8.2e-01
—
—
—
—
—
1.6e+00
cases:1.14%
controls:0.51%
—
—
—
—
—
—
—
—
—
—
cases:2.09%
controls:0.42%
7
30
605
5869
—
—
—
—
—
13
25
608
5922
Planned health check-up monitoring, health check-up performed based on individual need
SPAT1317 [2001700418]
3.0e-01
8.0e-01
1.1e+00
—
—
7.9e-01
3.2e-02
cases:16.67%
controls:12.95%
cases:10.02%
controls:4.74%
cases:1.54%
controls:0.52%
—
—
—
—
cases:6.49%
controls:3.06%
cases:7.09%
controls:6.88%
102
764
510
5135
65
294
584
5908
10
32
639
6170
—
—
42
189
605
5989
44
409
577
5538
Pediatric Gastroenterology
OMOP4822029 [45756810]
7.3e-01
6.8e-01
5.4e-01
—
—
8.1e-01
6.4e-01
cases:5.07%
controls:2.51%
cases:3.24%
controls:1.66%
cases:0.77%
controls:0.45%
—
—
—
—
cases:3.40%
controls:1.54%
cases:4.51%
controls:2.42%
31
148
581
5751
21
103
628
6099
5
28
644
6174
—
—
22
95
625
6083
28
144
593
5803
Physiotherapy
R4110 [2001310233]
5.3e-01
4.2e-01
2.0e-01
—
1.0e+00
7.9e-01
7.5e-01
cases:8.17%
controls:4.98%
cases:5.24%
controls:3.50%
cases:0.77%
controls:0.63%
—
—
cases:1.08%
controls:0.39%
cases:5.26%
controls:2.46%
cases:8.53%
controls:4.22%
50
294
562
5605
34
217
615
5985
5
39
644
6163
—
7
24
642
6177
34
152
613
6026
53
251
568
5696
Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
78445-4 [21492711]
1.5e+00
—
—
—
—
—
4.7e-02
cases:1.47%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
cases:1.13%
controls:1.08%
9
19
603
5880
—
—
—
—
—
7
64
614
5883
Mycophenolate [Mass/volume] in Serum or Plasma
23905-3 [3027653]
1.5e+00
—
—
—
—
—
7.2e-01
cases:1.47%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.47%
9
19
603
5880
—
—
—
—
—
6
28
615
5919
salbutamol; inhalant
R03AC02 [21603256]
3.6e-01
5.3e-01
5.7e-01
—
7.0e-01
5.0e-01
4.9e-01
cases:19.77%
controls:14.68%
cases:12.33%
controls:7.61%
cases:1.39%
controls:0.79%
—
—
cases:2.31%
controls:1.16%
cases:11.44%
controls:7.25%
cases:20.29%
controls:13.49%
121
866
491
5033
80
472
569
5730
9
49
640
6153
—
15
72
634
6129
74
448
573
5730
126
802
495
5145
Urinary tract ultrasound examination
KH1AE [2001306329]
3.4e-01
—
—
—
—
—
1.5e+00
cases:2.12%
controls:1.53%
—
—
—
—
—
—
—
—
—
—
cases:3.22%
controls:0.72%
13
90
599
5809
—
—
—
—
—
20
43
601
5904
Pulmonary Disease
29 [38004472]
9.3e-01
—
—
—
—
1.5e+00
1.5e+00
cases:0.98%
controls:0.39%
—
—
—
—
—
—
—
—
cases:0.77%
controls:0.18%
cases:3.70%
controls:0.86%
6
23
606
5876
—
—
—
—
5
11
642
6167
23
51
598
5896
Neurosurgery
14 [38004459]
6.4e-01
1.0e+00
—
—
—
—
1.5e+00
cases:1.31%
controls:0.70%
cases:0.77%
controls:0.27%
—
—
—
—
—
—
—
—
cases:1.93%
controls:0.45%
8
41
604
5858
5
17
644
6185
—
—
—
—
12
27
609
5920
Monocytes [#/volume] in Blood
26484-6 [3001604]
-6.2e-02
2.7e-01
5.9e-01
1.8e+00
8.5e-01
4.8e-01
5.9e-01
cases:8.99%
controls:9.51%
cases:10.02%
controls:7.82%
cases:3.54%
controls:2.00%
cases:0.92%
controls:0.16%
cases:4.47%
controls:1.97%
cases:9.58%
controls:6.18%
cases:18.52%
controls:11.20%
55
561
557
5338
65
485
584
5717
23
124
626
6078
6
10
643
6192
29
122
620
6079
62
382
585
5796
115
666
506
5281
Other and unspecified abdominal pain
R10.4 [45568113]
2.6e-01
8.1e-01
—
1.0e+50
—
7.2e-01
6.0e-01
cases:5.39%
controls:4.20%
cases:3.70%
controls:1.68%
—
—
cases:0.92%
controls:0.00%
—
—
cases:3.09%
controls:1.52%
cases:8.70%
controls:4.94%
33
248
579
5651
24
104
625
6098
—
6
0
643
6202
—
20
94
627
6084
54
294
567
5653
Outpatient Hospital
22 [8756]
1.2e-01
3.2e-01
8.4e-02
—
5.7e-01
9.5e-01
4.6e-01
cases:23.86%
controls:21.77%
cases:11.56%
controls:8.66%
cases:1.54%
controls:1.42%
—
—
cases:2.00%
controls:1.14%
cases:12.52%
controls:5.24%
cases:17.55%
controls:11.84%
146
1284
466
4615
75
537
574
5665
10
88
639
6114
—
13
71
636
6130
81
324
566
5854
109
704
512
5243
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
-9.1e-02
2.6e-01
5.8e-01
1.6e+00
8.7e-01
4.5e-01
5.4e-01
cases:9.15%
controls:9.93%
cases:10.32%
controls:8.14%
cases:3.54%
controls:2.02%
cases:0.92%
controls:0.19%
cases:4.62%
controls:1.98%
cases:9.74%
controls:6.44%
cases:18.68%
controls:11.84%
56
586
556
5313
67
505
582
5697
23
125
626
6077
6
12
643
6190
30
123
619
6078
63
398
584
5780
116
704
505
5243
amlodipine; oral
C08CA01 [21601747]
1.4e+00
1.1e+00
—
—
—
7.9e-01
1.2e-01
cases:1.63%
controls:0.41%
cases:1.23%
controls:0.42%
—
—
—
—
—
—
cases:1.24%
controls:0.57%
cases:0.97%
controls:0.86%
10
24
602
5875
8
26
641
6176
—
—
—
8
35
639
6143
6
51
615
5896
Obstetrics / Gynecology
16 [38004461]
-5.2e-01
—
—
—
—
1.4e+00
5.1e-01
cases:1.14%
controls:1.92%
—
—
—
—
—
—
—
—
cases:2.32%
controls:0.58%
cases:7.25%
controls:4.49%
7
113
605
5786
—
—
—
—
15
36
632
6142
45
267
576
5680
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
3.3e-01
7.3e-01
1.0e+00
—
1.1e+00
5.1e-01
6.7e-01
cases:4.58%
controls:3.32%
cases:5.86%
controls:2.92%
cases:1.39%
controls:0.50%
—
—
cases:1.85%
controls:0.61%
cases:5.10%
controls:3.12%
cases:12.24%
controls:6.66%
28
196
584
5703
38
181
611
6021
9
31
640
6171
—
12
38
637
6163
33
193
614
5985
76
396
545
5551
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
-4.6e-02
2.5e-01
5.6e-01
1.8e+00
8.5e-01
4.7e-01
5.4e-01
cases:9.15%
controls:9.54%
cases:10.02%
controls:7.95%
cases:3.54%
controls:2.05%
cases:0.92%
controls:0.16%
cases:4.47%
controls:1.97%
cases:9.74%
controls:6.33%
cases:18.36%
controls:11.54%
56
563
556
5336
65
493
584
5709
23
127
626
6075
6
10
643
6192
29
122
620
6079
63
391
584
5787
114
686
507
5261
Differential panel, method unspecified - Blood
69738-3 [42870588]
4.4e-02
2.4e-01
6.5e-01
1.5e+00
8.2e-01
4.8e-01
5.6e-01
cases:6.54%
controls:6.27%
cases:7.70%
controls:6.18%
cases:3.08%
controls:1.63%
cases:0.77%
controls:0.18%
cases:4.16%
controls:1.87%
cases:8.96%
controls:5.76%
cases:16.26%
controls:9.97%
40
370
572
5529
50
383
599
5819
20
101
629
6101
5
11
644
6191
27
116
622
6085
58
356
589
5822
101
593
520
5354
Procedure duration 50 to 59 minutes
ZXE06 [2001311400]
4.4e-01
-4.6e-02
—
—
—
6.2e-01
1.3e+00
cases:2.12%
controls:1.37%
cases:1.08%
controls:1.13%
—
—
—
—
—
—
cases:1.08%
controls:0.58%
cases:1.77%
controls:0.47%
13
81
599
5818
7
70
642
6132
—
—
—
7
36
640
6142
11
28
610
5919
Endomysium IgA Ab [Titer] in Serum
10863-9 [3020961]
4.6e-01
1.3e+00
—
1.0e+50
—
8.3e-01
1.2e-01
cases:2.94%
controls:1.88%
cases:2.93%
controls:0.81%
—
—
cases:0.77%
controls:0.00%
—
—
cases:1.55%
controls:0.68%
cases:2.09%
controls:1.87%
18
111
594
5788
19
50
630
6152
—
5
0
644
6202
—
10
42
637
6136
13
111
608
5836
Occupational therapy
R4120 [2001310234]
1.3e+00
7.7e-01
—
—
-1.0e+50
1.2e+00
3.9e-01
cases:1.80%
controls:0.49%
cases:1.08%
controls:0.50%
—
—
—
—
cases:0.00%
controls:0.10%
cases:1.24%
controls:0.39%
cases:2.42%
controls:1.65%
11
29
601
5870
7
31
642
6171
—
—
0
6
649
6195
8
24
639
6154
15
98
606
5849
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
3.0e-01
3.4e-01
8.8e-01
—
1.3e+00
4.6e-01
3.8e-01
cases:3.43%
controls:2.56%
cases:3.54%
controls:2.55%
cases:1.39%
controls:0.58%
—
—
cases:2.16%
controls:0.60%
cases:3.86%
controls:2.48%
cases:4.99%
controls:3.46%
21
151
591
5748
23
158
626
6044
9
36
640
6166
—
14
37
635
6164
25
153
622
6025
31
206
590
5741
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
1.7e-01
1.3e+00
—
—
—
8.8e-01
6.6e-01
cases:0.98%
controls:0.83%
cases:1.85%
controls:0.52%
—
—
—
—
—
—
cases:1.24%
controls:0.52%
cases:3.22%
controls:1.70%
6
49
606
5850
12
32
637
6170
—
—
—
8
32
639
6146
20
101
601
5846
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14928-6 [3026989]
—
—
—
—
—
1.5e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.77%
controls:0.18%
cases:2.09%
controls:0.59%
—
—
—
—
—
5
11
642
6167
13
35
608
5912
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
-1.5e-01
1.7e-02
6.9e-01
—
1.3e+00
4.9e-01
4.3e-01
cases:6.54%
controls:7.49%
cases:5.70%
controls:5.61%
cases:1.85%
controls:0.94%
—
—
cases:3.08%
controls:0.89%
cases:6.18%
controls:3.87%
cases:11.11%
controls:7.50%
40
442
572
5457
37
348
612
5854
12
58
637
6144
—
20
55
629
6146
40
239
607
5939
69
446
552
5501
Glomerular filtration rate (GFR) Isotope mesurement
KA1MN [2001305637]
1.2e+00
7.9e-01
-1.0e+50
—
—
8.3e-01
7.0e-01
cases:3.27%
controls:0.97%
cases:1.69%
controls:0.77%
cases:0.00%
controls:0.08%
—
—
—
—
cases:1.55%
controls:0.68%
cases:1.77%
controls:0.89%
20
57
592
5842
11
48
638
6154
0
5
649
6197
—
—
10
42
637
6136
11
53
610
5894
Pharmacy visit
OMOP4822462 [581458]
-1.8e-01
-8.7e-02
7.4e-02
1.2e+00
2.9e-01
2.3e-01
-9.3e-03
cases:83.99%
controls:86.32%
cases:61.48%
controls:63.51%
cases:23.57%
controls:22.27%
cases:3.54%
controls:1.06%
cases:27.73%
controls:22.37%
cases:67.54%
controls:62.32%
cases:85.83%
controls:85.94%
514
5092
98
807
399
3939
250
2263
153
1381
496
4821
23
66
626
6136
180
1387
469
4814
437
3850
210
2328
533
5111
88
836
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
1.8e-01
8.0e-01
—
—
1.3e+00
1.2e+00
6.4e-01
cases:2.29%
controls:1.92%
cases:3.24%
controls:1.48%
—
—
—
—
cases:0.92%
controls:0.26%
cases:2.94%
controls:0.94%
cases:4.67%
controls:2.52%
14
113
598
5786
21
92
628
6110
—
—
6
16
643
6185
19
58
628
6120
29
150
592
5797
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9728-7 [3025271]
7.3e-01
1.1e+00
—
—
—
5.0e-01
1.0e+00
cases:1.47%
controls:0.71%
cases:2.00%
controls:0.64%
—
—
—
—
—
—
cases:0.93%
controls:0.57%
cases:1.45%
controls:0.54%
9
42
603
5857
13
40
636
6162
—
—
—
6
35
641
6143
9
32
612
5915
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14135-8 [3001405]
7.3e-01
1.1e+00
—
—
—
5.0e-01
1.0e+00
cases:1.47%
controls:0.71%
cases:2.00%
controls:0.64%
—
—
—
—
—
—
cases:0.93%
controls:0.57%
cases:1.45%
controls:0.52%
9
42
603
5857
13
40
636
6162
—
—
—
6
35
641
6143
9
31
612
5916
CD3 cells [#/volume] in Blood
8122-4 [3011412]
7.1e-01
1.1e+00
—
—
—
6.2e-01
9.7e-01
cases:1.47%
controls:0.73%
cases:2.00%
controls:0.66%
—
—
—
—
—
—
cases:1.08%
controls:0.58%
cases:1.45%
controls:0.55%
9
43
603
5856
13
41
636
6161
—
—
—
7
36
640
6142
9
33
612
5914
fluticasone furoate
R03BA09 [45893496]
4.3e-01
4.0e-01
—
—
1.1e+00
3.9e-01
4.9e-01
cases:10.46%
controls:7.05%
cases:6.16%
controls:4.22%
—
—
—
—
cases:2.16%
controls:0.73%
cases:5.56%
controls:3.85%
cases:8.53%
controls:5.43%
64
416
548
5483
40
262
609
5940
—
—
14
45
635
6156
36
238
611
5940
53
323
568
5624
Left side
ZXA05 [2001311347]
5.4e-01
3.6e-01
-1.0e+50
—
—
—
1.1e+00
cases:3.10%
controls:1.83%
cases:0.92%
controls:0.64%
cases:0.00%
controls:0.08%
—
—
—
—
—
—
cases:2.58%
controls:0.87%
19
108
593
5791
6
40
643
6162
0
5
649
6197
—
—
—
16
52
605
5895
CD3-CD19+ cells/cells in Blood
15196-9 [3006245]
6.9e-01
1.1e+00
—
—
—
4.7e-01
1.0e+00
cases:1.47%
controls:0.75%
cases:2.00%
controls:0.68%
—
—
—
—
—
—
cases:0.93%
controls:0.58%
cases:1.61%
controls:0.57%
9
44
603
5855
13
42
636
6160
—
—
—
6
36
641
6142
10
34
611
5913
B lymphocytes [#/volume] in Blood
11130-2 [3000060]
7.1e-01
1.1e+00
—
—
—
5.0e-01
1.1e+00
cases:1.47%
controls:0.73%
cases:2.00%
controls:0.68%
—
—
—
—
—
—
cases:0.93%
controls:0.57%
cases:1.61%
controls:0.52%
9
43
603
5856
13
42
636
6160
—
—
—
6
35
641
6143
10
31
611
5916
fluticasone; inhalant
R03BA05 [21603288]
4.1e-01
3.7e-01
—
—
1.1e+00
3.8e-01
4.6e-01
cases:10.78%
controls:7.46%
cases:6.16%
controls:4.34%
—
—
—
—
cases:2.16%
controls:0.76%
cases:5.72%
controls:3.97%
cases:8.53%
controls:5.55%
66
440
546
5459
40
269
609
5933
—
—
14
47
635
6154
37
245
610
5933
53
330
568
5617
Pediatric Surgery
OMOP4822020 [45756819]
2.0e-01
4.1e-01
8.1e-01
—
2.3e-01
6.4e-01
4.1e-01
cases:16.01%
controls:13.49%
cases:11.09%
controls:7.63%
cases:2.93%
controls:1.32%
—
—
cases:1.54%
controls:1.23%
cases:11.13%
controls:6.20%
cases:17.55%
controls:12.33%
98
796
514
5103
72
473
577
5729
19
82
630
6120
—
10
76
639
6125
72
383
575
5795
109
733
512
5214
Tooth plaque
K03.66 [2000502691]
6.0e-01
4.6e-01
—
—
—
1.0e+00
2.8e-01
cases:4.41%
controls:2.47%
cases:2.16%
controls:1.37%
—
—
—
—
—
—
cases:4.17%
controls:1.51%
cases:7.57%
controls:5.83%
27
146
585
5753
14
85
635
6117
—
—
—
27
93
620
6085
47
347
574
5600
Examination of ears and hearing
Z01.1 [45547279]
4.9e-01
6.7e-01
—
—
—
1.0e+00
5.1e-01
cases:7.68%
controls:4.83%
cases:2.00%
controls:1.03%
—
—
—
—
—
—
cases:2.94%
controls:1.05%
cases:4.67%
controls:2.86%
47
285
565
5614
13
64
636
6138
—
—
—
19
65
628
6113
29
170
592
5777
Headache
R51.80 [2000503603]
6.8e-01
9.0e-01
-1.0e+50
—
—
1.0e+00
2.3e-01
cases:3.76%
controls:1.93%
cases:1.85%
controls:0.76%
cases:0.00%
controls:0.16%
—
—
—
—
cases:2.16%
controls:0.78%
cases:3.54%
controls:2.82%
23
114
589
5785
12
47
637
6155
0
10
649
6192
—
—
14
48
633
6130
22
168
599
5779
levothyroxine sodium; oral, parenteral
H03AA01 [21602754]
1.5e-01
-1.7e-02
—
—
—
1.0e+00
6.9e-01
cases:1.14%
controls:0.98%
cases:1.08%
controls:1.10%
—
—
—
—
—
—
cases:3.25%
controls:1.18%
cases:4.51%
controls:2.30%
7
58
605
5841
7
68
642
6134
—
—
—
21
73
626
6105
28
137
593
5810
Asthma
J45 [45596282]
1.0e+00
4.5e-01
—
—
-1.0e+50
7.8e-01
6.9e-01
cases:7.52%
controls:2.85%
cases:1.39%
controls:0.89%
—
—
—
—
cases:0.00%
controls:0.08%
cases:1.55%
controls:0.71%
cases:3.70%
controls:1.90%
46
168
566
5731
9
55
640
6147
—
—
0
5
649
6196
10
44
637
6134
23
113
598
5834
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.0e+00
9.4e-01
—
—
1.7e+00
4.5e-01
4.6e-01
cases:2.94%
controls:1.10%
cases:2.31%
controls:0.92%
—
—
—
—
cases:1.08%
controls:0.19%
cases:2.16%
controls:1.39%
cases:4.83%
controls:3.11%
18
65
594
5834
15
57
634
6145
—
—
7
12
642
6189
14
86
633
6092
30
185
591
5762
Dietary counselling and surveillance
Z71.3 [45552101]
1.0e+00
5.6e-01
—
—
—
1.2e+00
3.0e-01
cases:2.45%
controls:0.92%
cases:0.92%
controls:0.53%
—
—
—
—
—
—
cases:1.08%
controls:0.32%
cases:1.45%
controls:1.08%
15
54
597
5845
6
33
643
6169
—
—
—
7
20
640
6158
9
64
612
5883
aciclovir; oral, parenteral
J05AB01 [21603131]
9.9e-01
—
—
—
—
—
-1.9e-01
cases:2.78%
controls:1.05%
—
—
—
—
—
—
—
—
—
—
cases:1.13%
controls:1.36%
17
62
595
5837
—
—
—
—
—
7
81
614
5866
Neuropsychological investigation
XA800 [2001300412]
7.3e-01
3.6e-01
-1.0e+50
—
—
6.1e-01
9.8e-01
cases:3.43%
controls:1.68%
cases:1.08%
controls:0.76%
cases:0.00%
controls:0.15%
—
—
—
—
cases:1.39%
controls:0.76%
cases:2.90%
controls:1.11%
21
99
591
5800
7
47
642
6155
0
9
649
6193
—
—
9
47
638
6131
18
66
603
5881
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
R5110 [2001310246]
9.6e-01
5.3e-01
—
—
—
1.0e+00
9.0e-01
cases:2.61%
controls:1.02%
cases:1.23%
controls:0.73%
—
—
—
—
—
—
cases:1.70%
controls:0.63%
cases:2.42%
controls:0.99%
16
60
596
5839
8
45
641
6157
—
—
—
11
39
636
6139
15
59
606
5888
Urgent procedure
ZXD05 [2001311386]
4.1e-01
4.9e-01
—
—
—
6.0e-01
9.5e-01
cases:5.39%
controls:3.64%
cases:1.85%
controls:1.14%
—
—
—
—
—
—
cases:1.08%
controls:0.60%
cases:3.70%
controls:1.46%
33
215
579
5684
12
71
637
6131
—
—
—
7
37
640
6141
23
87
598
5860
Orthodontic treatment/control appointment, short
SJX10 [2001310452]
1.2e-02
-1.9e-01
—
—
—
1.8e-01
9.3e-01
cases:2.78%
controls:2.75%
cases:0.92%
controls:1.11%
—
—
—
—
—
—
cases:0.93%
controls:0.78%
cases:4.83%
controls:1.97%
17
162
595
5737
6
69
643
6133
—
—
—
6
48
641
6130
30
117
591
5830
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
9.1e-01
4.5e-01
—
—
—
5.6e-01
8.5e-01
cases:2.94%
controls:1.20%
cases:1.08%
controls:0.69%
—
—
—
—
—
—
cases:0.93%
controls:0.53%
cases:3.06%
controls:1.33%
18
71
594
5828
7
43
642
6159
—
—
—
6
33
641
6145
19
79
602
5868
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
2.8e-01
8.8e-01
—
—
—
1.1e-01
1.0e-01
cases:3.76%
controls:2.86%
cases:4.31%
controls:1.84%
—
—
—
—
—
—
cases:1.85%
controls:1.67%
cases:6.92%
controls:6.31%
23
169
589
5730
28
114
621
6088
—
—
—
12
103
635
6075
43
375
578
5572
Asthma, unspecified
J45.9 [45562456]
8.8e-01
6.0e-01
—
—
1.3e+00
7.9e-01
6.5e-01
cases:5.07%
controls:2.17%
cases:2.16%
controls:1.19%
—
—
—
—
cases:0.77%
controls:0.21%
cases:2.01%
controls:0.92%
cases:4.03%
controls:2.15%
31
128
581
5771
14
74
635
6128
—
—
5
13
644
6188
13
57
634
6121
25
128
596
5819
salmeterol and fluticasone
R03AK06 [21603280]
7.4e-01
5.2e-01
—
—
1.1e+00
8.7e-01
6.0e-01
cases:3.10%
controls:1.51%
cases:2.47%
controls:1.48%
—
—
—
—
cases:1.08%
controls:0.35%
cases:3.40%
controls:1.46%
cases:4.67%
controls:2.61%
19
89
593
5810
16
92
633
6110
—
—
7
22
642
6179
22
90
625
6088
29
155
592
5792
General anaesthesia
WX402 [2001310806]
4.2e-01
2.9e-01
—
—
—
8.7e-01
1.4e-01
cases:2.78%
controls:1.85%
cases:2.31%
controls:1.74%
—
—
—
—
—
—
cases:3.25%
controls:1.39%
cases:6.12%
controls:5.35%
17
109
595
5790
15
108
634
6094
—
—
—
21
86
626
6092
38
318
583
5629
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
6.9e-01
6.3e-01
9.2e-01
1.0e+50
1.0e+00
4.7e-01
8.5e-01
cases:4.25%
controls:2.17%
cases:3.39%
controls:1.84%
cases:0.92%
controls:0.37%
cases:0.77%
controls:0.00%
cases:1.23%
controls:0.44%
cases:2.63%
controls:1.65%
cases:5.48%
controls:2.40%
26
128
586
5771
22
114
627
6088
6
23
643
6179
5
0
644
6202
8
27
641
6174
17
102
630
6076
34
143
587
5804
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
3.3e-02
8.5e-01
—
—
—
3.3e-01
7.7e-01
cases:2.45%
controls:2.37%
cases:3.08%
controls:1.34%
—
—
—
—
—
—
cases:1.24%
controls:0.89%
cases:3.06%
controls:1.45%
15
140
597
5759
20
83
629
6119
—
—
—
8
55
639
6123
19
86
602
5861
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
6.4e-01
5.3e-01
—
—
1.2e+00
4.5e-01
8.1e-01
cases:2.94%
controls:1.58%
cases:2.47%
controls:1.47%
—
—
—
—
cases:0.92%
controls:0.27%
cases:2.32%
controls:1.49%
cases:4.67%
controls:2.14%
18
93
594
5806
16
91
633
6111
—
—
6
17
643
6184
15
92
632
6086
29
127
592
5820
Removal of fixed intravenous catheter
TPH90 [2001309607]
8.0e-01
—
—
—
—
—
1.0e+00
cases:4.58%
controls:2.10%
—
—
—
—
—
—
—
—
—
—
cases:1.13%
controls:0.40%
28
124
584
5775
—
—
—
—
—
7
24
614
5923
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
6.9e-01
5.2e-01
—
—
1.2e+00
5.2e-01
7.9e-01
cases:3.10%
controls:1.58%
cases:2.47%
controls:1.48%
—
—
—
—
cases:0.92%
controls:0.27%
cases:2.63%
controls:1.59%
cases:4.83%
controls:2.25%
19
93
593
5806
16
92
633
6110
—
—
6
17
643
6184
17
98
630
6080
30
134
591
5813
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
7.8e-01
2.9e-01
—
—
—
-8.4e-02
2.1e-01
cases:3.92%
controls:1.83%
cases:1.69%
controls:1.27%
—
—
—
—
—
—
cases:1.24%
controls:1.34%
cases:5.15%
controls:4.20%
24
108
588
5791
11
79
638
6123
—
—
—
8
83
639
6095
32
250
589
5697
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
2.2e-01
7.1e-01
-1.0e+50
—
—
8.0e-01
7.7e-01
cases:3.92%
controls:3.19%
cases:1.85%
controls:0.92%
cases:0.00%
controls:0.08%
—
—
—
—
cases:2.16%
controls:0.99%
cases:4.35%
controls:2.07%
24
188
588
5711
12
57
637
6145
0
5
649
6197
—
—
14
61
633
6117
27
123
594
5824
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
5.2e-01
7.6e-01
1.3e+00
—
1.1e+00
6.6e-01
2.9e-01
cases:7.84%
controls:4.83%
cases:4.01%
controls:1.92%
cases:0.92%
controls:0.24%
—
—
cases:1.08%
controls:0.35%
cases:3.71%
controls:1.96%
cases:8.37%
controls:6.39%
48
285
564
5614
26
119
623
6083
6
15
643
6187
—
7
22
642
6179
24
121
623
6057
52
380
569
5567
ECG with 12 standard connections
XF400 [2001303368]
4.2e-02
6.1e-03
—
—
-1.0e+50
6.4e-01
7.5e-01
cases:5.56%
controls:5.34%
cases:2.77%
controls:2.76%
—
—
—
—
cases:0.00%
controls:0.24%
cases:2.78%
controls:1.49%
cases:5.31%
controls:2.57%
34
315
578
5584
18
171
631
6031
—
—
0
15
649
6186
18
92
629
6086
33
153
588
5794
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
5.4e-01
4.3e-01
—
—
1.3e+00
3.7e-01
7.4e-01
cases:2.94%
controls:1.73%
cases:2.62%
controls:1.73%
—
—
—
—
cases:1.08%
controls:0.29%
cases:2.47%
controls:1.72%
cases:4.99%
controls:2.44%
18
102
594
5797
17
107
632
6095
—
—
7
18
642
6183
16
106
631
6072
31
145
590
5802
Short blood count panel - Blood
55429-5 [40758558]
-1.9e-01
2.8e-02
-5.7e-02
1.4e+00
7.9e-01
2.8e-01
7.0e-01
cases:6.86%
controls:8.20%
cases:6.01%
controls:5.85%
cases:1.39%
controls:1.47%
cases:0.77%
controls:0.19%
cases:2.62%
controls:1.21%
cases:5.10%
controls:3.92%
cases:8.86%
controls:4.62%
42
484
570
5415
39
363
610
5839
9
91
640
6111
5
12
644
6190
17
75
632
6126
33
242
614
5936
55
275
566
5672
prednisolone; oral, parenteral
H02AB06 [21602734]
2.3e-01
6.4e-01
—
—
—
7.0e-01
6.9e-01
cases:4.58%
controls:3.66%
cases:1.85%
controls:0.98%
—
—
—
—
—
—
cases:1.55%
controls:0.78%
cases:5.48%
controls:2.82%
28
216
584
5683
12
61
637
6141
—
—
—
10
48
637
6130
34
168
587
5779
prednisolone
A07EA01 [21600653]
2.3e-01
6.4e-01
—
—
—
7.0e-01
6.8e-01
cases:4.58%
controls:3.68%
cases:1.85%
controls:0.98%
—
—
—
—
—
—
cases:1.55%
controls:0.78%
cases:5.48%
controls:2.84%
28
217
584
5682
12
61
637
6141
—
—
—
10
48
637
6130
34
169
587
5778
Neonatal screening
60151004 [4246502]
6.4e-01
4.4e-01
—
—
—
7.2e-01
7.7e-01
cases:7.19%
controls:3.93%
cases:1.69%
controls:1.10%
—
—
—
—
—
—
cases:1.55%
controls:0.76%
cases:2.25%
controls:1.06%
44
232
568
5667
11
68
638
6134
—
—
—
10
47
637
6131
14
63
607
5884
antibiotics in combination with other drugs
S01AA20 [21603571]
6.1e-01
2.7e-01
—
—
—
1.4e-01
3.7e-01
cases:7.84%
controls:4.42%
cases:1.85%
controls:1.42%
—
—
—
—
—
—
cases:1.39%
controls:1.21%
cases:4.83%
controls:3.40%
48
261
564
5638
12
88
637
6114
—
—
—
9
75
638
6103
30
202
591
5745
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
7.1e-02
4.6e-01
—
—
5.4e-01
4.2e-01
6.0e-01
cases:3.92%
controls:3.66%
cases:4.16%
controls:2.68%
—
—
—
—
cases:1.08%
controls:0.63%
cases:3.71%
controls:2.48%
cases:6.44%
controls:3.63%
24
216
588
5683
27
166
622
6036
—
—
7
39
642
6162
24
153
623
6025
40
216
581
5731
combinations of corticosteroids
D07XB30 [21602188]
4.8e-01
5.4e-01
—
—
—
-7.9e-02
2.6e-01
cases:11.60%
controls:7.51%
cases:3.85%
controls:2.29%
—
—
—
—
—
—
cases:2.47%
controls:2.67%
cases:9.34%
controls:7.33%
71
443
541
5456
25
142
624
6060
—
—
—
16
165
631
6013
58
436
563
5511
combinations of corticosteroids
D07AB30 [21602118]
4.8e-01
5.4e-01
—
—
—
-7.9e-02
2.6e-01
cases:11.60%
controls:7.51%
cases:3.85%
controls:2.29%
—
—
—
—
—
—
cases:2.47%
controls:2.67%
cases:9.34%
controls:7.33%
71
443
541
5456
25
142
624
6060
—
—
—
16
165
631
6013
58
436
563
5511
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
4.0e-01
4.8e-01
1.9e-01
2.1e+00
5.7e-01
4.5e-01
4.5e-01
cases:8.66%
controls:5.97%
cases:6.78%
controls:4.32%
cases:1.85%
controls:1.53%
cases:0.77%
controls:0.10%
cases:2.93%
controls:1.68%
cases:6.96%
controls:4.53%
cases:14.81%
controls:9.94%
53
352
559
5547
44
268
605
5934
12
95
637
6107
5
6
644
6196
19
104
630
6097
45
280
602
5898
92
591
529
5356
Excision of other lesion extending through all layers of skin of trunk
QBE10 [2001309853]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.27%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
0
16
612
5883
—
—
—
—
—
0
15
621
5932
atomoxetine; oral
N06BA09 [21604762]
—
—
—
—
—
—
1.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.27%
—
—
—
—
—
—
5
16
616
5931
erythromycin; oral, parenteral
J01FA01 [21602970]
-2.6e-02
—
—
—
—
—
—
cases:2.78%
controls:2.85%
—
—
—
—
—
—
—
—
—
—
—
—
17
168
595
5731
—
—
—
—
—
—
Suture or reinsertion of tendon of wrist or hand, flexor tendon
NDL30 [2001307711]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
0
6
621
5941
Non-organic nocturnal and diurnal enuresis
F98.02 [2000502049]
1.3e+00
—
—
—
—
—
—
cases:0.82%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
—
—
5
13
607
5886
—
—
—
—
—
—
hydroxyethylpromethazine, combinations
R06AD55 [21603490]
-2.9e-01
—
—
—
—
—
1.8e-01
cases:2.94%
controls:3.88%
—
—
—
—
—
—
—
—
—
—
cases:1.61%
controls:1.35%
18
229
594
5670
—
—
—
—
—
10
80
611
5867
Open wound in the temple-jaw region
S01.41 [2000503612]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
612
5892
—
—
—
—
—
—
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.2 [45591172]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
0
6
649
6196
—
—
—
—
—
Neck ultrasound examination
EP1AE [2001302284]
6.3e-01
—
—
—
—
—
7.8e-01
cases:1.14%
controls:0.61%
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.37%
7
36
605
5863
—
—
—
—
—
5
22
616
5925
SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
26975-3 [3025245]
1.6e+00
—
—
—
—
—
—
cases:0.82%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
—
—
5
10
607
5889
—
—
—
—
—
—
prochlorperazine; oral, parenteral, rectal
N05AB04 [21604503]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
—
0
18
612
5881
—
—
—
—
—
—
insulin glulisine; parenteral
A10AB06 [21600720]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.10%
cases:0.00%
controls:0.11%
—
—
—
—
—
—
cases:0.00%
controls:0.16%
cases:0.00%
controls:0.27%
0
6
612
5893
0
7
649
6195
—
—
—
0
10
647
6168
0
16
621
5931
Restricted oral and dental health check by dental hygienist or dental assistant
SAB01 [2001310279]
7.3e-02
—
-1.0e+50
—
-1.0e+50
—
-8.2e-02
cases:10.62%
controls:9.95%
—
—
cases:0.00%
controls:0.11%
—
—
cases:0.00%
controls:0.16%
—
—
cases:2.58%
controls:2.79%
65
587
547
5312
—
0
7
649
6195
—
0
10
649
6191
—
16
166
605
5781
Allergy, unspecified
T78.4 [45580373]
3.2e-01
—
—
—
—
—
—
cases:1.31%
controls:0.95%
—
—
—
—
—
—
—
—
—
—
—
—
8
56
604
5843
—
—
—
—
—
—
Congestive heart failure
I50.0 [45567179]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
612
5894
—
—
—
—
—
—
Suppurative and unspecified otitis media
H66 [45538332]
1.9e-01
—
—
—
—
—
—
cases:2.12%
controls:1.76%
—
—
—
—
—
—
—
—
—
—
—
—
13
104
599
5795
—
—
—
—
—
—
Acute stress reaction
P02 [2002000799]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
0
8
621
5939
cycloSPORINE [Mass/volume] in Blood
3520-4 [3010375]
9.8e-01
—
—
—
—
—
7.3e-01
cases:1.47%
controls:0.56%
—
—
—
—
—
—
—
—
—
—
cases:1.45%
controls:0.71%
9
33
603
5866
—
—
—
—
—
9
42
612
5905
Pervasive developmental disorder, unspecified
F84.9 [45600763]
7.3e-01
—
—
—
—
—
7.4e-01
cases:0.98%
controls:0.47%
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.39%
6
28
606
5871
—
—
—
—
—
5
23
616
5924
Implementation of speech therapy rehabilitation plan
SPAT1224 [2001700325]
2.6e-01
—
-1.0e+50
—
-1.0e+50
—
—
cases:1.14%
controls:0.88%
—
—
cases:0.00%
controls:0.11%
—
—
cases:0.00%
controls:0.10%
—
—
—
—
7
52
605
5847
—
0
7
649
6195
—
0
6
649
6195
—
—
rubella, live attenuated
J07BJ01 [21601359]
8.4e-02
2.1e-01
—
—
—
3.7e-01
-1.5e-01
cases:9.31%
controls:8.63%
cases:2.47%
controls:2.02%
—
—
—
—
—
—
cases:2.63%
controls:1.83%
cases:6.12%
controls:7.01%
57
509
555
5390
16
125
633
6077
—
—
—
17
113
630
6065
38
417
583
5530
dexamethasone
S03BA01 [21605201]
1.0e+00
1.7e+00
—
—
—
—
2.6e-01
cases:1.63%
controls:0.59%
cases:0.77%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.45%
controls:1.13%
10
35
602
5864
5
9
644
6193
—
—
—
—
9
67
612
5880
Skin cryotherapy, unspecified location
QXA50 [2001310044]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
0
5
647
6173
—
Contusion of thorax
S20.2 [45597402]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
612
5893
—
—
—
—
—
—
Surgical exposure of tooth
ECA00 [2001301956]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
612
5894
—
—
—
—
—
—
Acute gingivitis, UNS
K05.09 [2000502716]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.15%
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
0
9
612
5890
0
5
649
6197
—
—
—
—
—
Ventricular septal defect NOS
Q21.09 [2000503269]
—
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
0
7
649
6195
—
—
—
—
Dentinal dysplasia
K00.50 [2000502640]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
—
—
—
0
21
621
5926
Acute appendicitis with peritoneal abscess
K35.1 [45586713]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
0
10
621
5937
Congenital mitral insufficiency
Q23.3 [45572955]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
—
0
5
649
6197
—
—
—
0
5
647
6173
—
Chronic coagulation defects
126 [2001600124]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.15%
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
0
9
612
5890
0
5
649
6197
—
—
—
—
—
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
0
5
621
5942
Cathetrisation of artery
TPH07 [2001309747]
4.0e-01
—
—
—
—
—
4.9e-01
cases:2.78%
controls:1.88%
—
—
—
—
—
—
—
—
—
—
cases:1.45%
controls:0.89%
17
111
595
5788
—
—
—
—
—
9
53
612
5894
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
32787-4 [3043453]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.00%
controls:0.32%
—
—
—
—
—
0
5
647
6173
0
19
621
5928
Dislocation of elbow, unspecified
S53.1 [45607666]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
0
13
621
5934
Short stature NOS
E34.30 [2000501484]
—
—
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
—
—
—
—
—
cases:14.95%
controls:0.00%
cases:4.47%
controls:0.00%
cases:9.43%
controls:0.00%
cases:10.79%
controls:0.00%
—
—
—
97
0
552
6202
29
0
620
6201
61
0
586
6178
67
0
554
5947
Presence of electronic cardiac devices
Z95.0 [45571406]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.08%
cases:0.00%
controls:0.11%
—
—
—
—
—
—
cases:0.00%
controls:0.13%
cases:0.00%
controls:0.17%
0
5
612
5894
0
7
649
6195
—
—
—
0
8
647
6170
0
10
621
5937
Simple partial seizures
G40.10 [2000502135]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
0
6
647
6172
—
Radiologic consultation
XX2VW [2001311018]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
0
5
621
5942
Liquor cerebri shunt X-ray examinatin without contrast
AA7AA [2001300207]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
612
5894
—
—
—
—
—
—
Skin colour change
S08 [2002000973]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.00%
controls:0.27%
—
—
—
—
—
0
5
647
6173
0
16
621
5931
Neonatal-Perinatal Medicine
OMOP4821957 [45756786]
-2.6e-01
—
—
—
—
-1.0e+50
—
cases:1.63%
controls:2.10%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
10
124
602
5775
—
—
—
—
0
5
647
6173
—
carbamide
D02AE01 [21601975]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
0
16
649
6186
—
—
—
0
11
647
6167
—
hydrocortisone
A07EA02 [21600654]
2.7e-01
4.6e-01
—
—
9.1e-01
3.1e-01
2.6e-01
cases:12.91%
controls:10.17%
cases:5.24%
controls:3.37%
—
—
—
—
cases:1.23%
controls:0.50%
cases:4.64%
controls:3.43%
cases:10.31%
controls:8.14%
79
600
533
5299
34
209
615
5993
—
—
8
31
641
6170
30
212
617
5966
64
484
557
5463
Thorax CT examination
GD1AD [2001303618]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
0
6
649
6196
—
—
—
—
—
Passage examination of small bowell with X-ray
JF1AB [2001304810]
1.2e+00
—
—
—
—
—
—
cases:0.98%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
6
17
606
5882
—
—
—
—
—
—
Contusion of other and unspecified parts of forearm
S50.1 [45578434]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
0
6
621
5941
xylometazoline
R01AB06 [21605029]
4.7e-02
—
—
—
—
—
3.8e-01
cases:1.63%
controls:1.56%
—
—
—
—
—
—
—
—
—
—
cases:1.45%
controls:0.99%
10
92
602
5807
—
—
—
—
—
9
59
612
5888
Enteroviral vesicular stomatitis with exanthem
B08.4 [45585948]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
0
5
649
6197
—
—
—
—
—
Injury of muscle and tendon of the posterior muscle group at thigh level
S76.3 [45593843]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
0
5
621
5942
Red eye
F02 [2002000400]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.16%
—
—
—
0
16
649
6186
—
—
—
0
10
647
6168
—
flucloxacillin; oral, parenteral
J01CF05 [21602857]
-1.0e+50
—
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
cases:0.00%
controls:0.49%
0
6
612
5893
—
—
—
—
0
6
647
6172
0
29
621
5918
Nonorganic disorder of the sleep-wake schedule
F51.2 [45562056]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
612
5890
—
—
—
—
—
—
Extraoral traction arrangements and operation instruction, removable appliance
SJB30 [2001310424]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
0
20
647
6158
—
von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
68324-3 [40770918]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
—
0
7
649
6195
—
—
—
0
5
647
6173
—
buspirone; oral
N05BE01 [21604601]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
0
5
621
5942

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
148
22
74.35
255.34
6.3
3.0
1.99
3.73
ug/l
1.24
148
22
135
185
7.77
86.73
1.7
1.7
19.77
20.12
ng/l
0.08
135
185
188
458
4.54
65.09
2.7
1.9
3.93
5.99
u/l
4.19
112
288
182
441
4.54
63.35
2.7
1.9
6.77
7.22
iu/l
0.13
119
284
250
775
3.75
61.98
2.9
2.5
320.82
362.19
nmol/l
2.67
244
739
328
1214
3.36
61.70
15.6
11.6
1.34
1.33
mmol/l
0.39
310
1167
316
1498
2.47
33.79
3.5
2.8
2.41
2.39
mmol/l
1.55
299
1394
58
87
6.53
33.74
1.0
1.0
—
—
—
0
0
752
5272
2.92
32.92
5.5
3.9
14.41
14.43
pmol/l
0.05
727
4855
598
3827
2.33
30.74
9.0
5.9
127.31
109.64
u/l
5.61
569
3618
55
90
5.96
29.36
1.9
2.2
148.49
128.35
ng/l
0.86
55
85
138
462
3.09
28.65
2.8
1.9
8.27
11.19
nmol/l
3.26
131
420
617
4122
2.22
26.69
4.7
3.3
33.93
35.63
mmol/mol
6.92
606
3943
794
5974
2.92
25.46
5.9
4.5
1.90
1.86
mu/l
0.58
775
5688
171
705
2.54
23.69
5.1
4.9
0.21
0.21
g/l
0.01
166
683
475
3027
1.96
21.23
1.7
1.9
0.94
3.13
u/ml
3.66
68
618
248
1257
2.14
21.02
6.2
3.6
7.38
7.39
ph
1.09
174
839
460
2926
1.93
20.39
5.7
3.4
71.76
67.51
nmol/l
3.26
447
2794
577
3984
1.95
19.69
14.3
9.6
3.41
3.13
%
1.32
564
3809
575
3969
1.94
19.59
14.5
9.7
0.62
0.64
%
0.42
561
3807
577
4000
1.93
19.25
14.4
9.7
8.39
8.29
%
0.45
564
3828
405
2508
1.90
19.08
10.9
7.9
—
—
—
0
0
594
4165
1.94
19.05
13.8
9.5
0.57
0.55
e9/l
0.95
508
3458
625
4460
1.97
19.00
17.4
11.2
3.40
3.60
e9/l
1.67
542
3685
183
854
2.24
18.86
4.7
3.1
20.94
22.33
%
0.76
177
821
243
1268
2.06
18.79
1.4
1.3
—
—
—
0
0
606
4288
1.94
18.77
15.6
10.2
0.24
0.21
e9/l
1.46
530
3636
445
2853
1.88
18.70
2.2
1.7
1.54
1.66
g/l
1.19
209
1588
592
4160
1.92
18.68
13.9
9.5
0.04
0.04
e9/l
0.24
506
3457
585
4113
1.90
18.19
13.9
9.3
48.35
50.54
%
3.73
576
3999
591
4203
1.88
17.30
14.1
9.4
36.50
34.54
%
3.49
578
4056
465
3083
1.82
16.97
15.9
10.2
—
—
—
0
0
601
4312
1.87
16.92
13.8
9.4
2.46
2.29
e9/l
2.28
525
3710
343
2097
1.83
16.11
12.4
7.7
38.33
38.28
g/l
0.06
321
1999
202
1036
2.04
16.09
4.7
2.9
13.29
14.19
umol/l
1.05
196
988
457
3055
1.78
15.83
22.3
11.6
1.23
1.22
mmol/l
0.44
420
2832
187
938
2.07
15.80
4.7
2.9
2.55
2.58
g/l
0.27
180
884
553
3944
1.77
14.97
16.8
11.5
0.00
0.00
e9/l
0.47
427
3032
432
2876
1.75
14.86
25.1
13.4
1.23
1.23
mmol/l
0.99
415
2756
107
444
2.40
14.29
2.9
3.6
4.87
5.02
pmol/l
0.65
100
405
27
51
5.03
12.37
1.4
1.2
114.67
121.29
pmol/l
0.21
27
51
226
1309
1.80
12.09
17.7
12.4
—
—
—
0
0
33
77
4.08
11.74
2.4
2.3
—
—
—
0
0
238
1433
1.73
11.00
19.7
9.9
0.65
1.07
mmol/l
0.85
189
1174
239
1441
1.73
10.99
19.9
10.0
7.37
7.37
ph
0.50
183
973
50
173
2.78
9.66
1.5
1.4
383.55
373.17
ug/g
0.13
32
82
298
1963
1.61
9.52
3.7
3.1
2.38
2.35
mg/l
0.08
273
1746
157
872
1.81
9.45
9.4
6.4
1.33
1.39
%
0.58
149
833
168
963
1.76
9.07
1.3
1.2
—
64.80
—
0
5
26
62
3.97
9.01
1.6
2.4
20.25
19.50
nmol/l
—
8
20
121
628
1.91
9.00
6.9
5.0
57.51
62.69
e9/l
0.91
72
354
54
206
2.52
8.64
2.7
2.2
—
—
—
0
0
54
206
2.52
8.64
2.7
2.2
—
—
—
0
0
53
206
2.47
8.17
2.8
2.2
—
—
—
0
0
53
206
2.47
8.17
2.8
2.2
—
—
—
0
0
796
6710
1.84
8.01
14.1
9.3
24.40
25.22
u/l
0.49
783
6525
47
176
2.56
7.83
1.9
1.5
0.25
0.36
nmol/l
1.01
37
144
23
56
3.88
7.77
4.0
3.3
—
—
—
0
0
141
803
1.74
7.72
6.2
4.8
290.57
292.90
umol/l
0.09
132
764
53
213
2.39
7.61
5.8
3.5
1694.93
1511.07
e6/l
0.47
42
147
110
584
1.85
7.61
2.0
1.8
2.41
2.40
mmol/l
0.37
91
496
21
51
3.88
7.13
1.8
1.7
1.14
0.88
iu/ml
0.41
11
29
213
1380
1.56
6.99
5.0
2.9
571.36
586.92
mosm/kgh2o
0.36
190
1209
60
267
2.16
6.81
3.4
3.6
10.34
21.52
mu/l
5.11
60
255
150
898
1.66
6.80
1.2
1.4
—
152.00
—
0
38
65
299
2.09
6.79
1.9
1.4
10.54
4.13
ug/l
1.20
60
288
151
908
1.65
6.73
2.0
1.4
384.63
276.55
u/ml
0.65
141
859
806
6896
1.77
6.60
26.4
15.6
13.21
13.09
%
2.25
800
6820
115
646
1.74
6.58
21.3
14.4
105.65
105.79
mmol/l
0.09
115
646
49
205
2.28
6.46
6.0
3.4
700.38
539.01
e6/l
1.02
37
137
49
206
2.27
6.39
6.1
3.4
176.27
204.00
e6/l
0.41
37
139
94
504
1.81
6.30
7.7
7.7
22.01
22.51
s
0.60
89
484
219
1465
1.51
6.12
4.8
3.0
8.09
7.45
e6/l
0.22
199
1295
527
4166
1.41
5.92
5.1
3.6
59.93
53.39
ug/l
0.52
507
3972
20
54
3.49
5.88
3.5
3.5
884.05
1087.00
u/ml
0.31
20
54
135
824
1.61
5.64
7.3
3.7
8.96
9.38
g/l
0.77
130
791
230
1580
1.47
5.58
3.2
3.4
76.02
94.90
ug/g
0.94
183
1285
21
61
3.24
5.54
4.0
2.1
—
—
—
0
0
332
2456
1.40
5.32
11.7
7.7
15.83
20.15
umol/l
1.25
311
2269
45
198
2.16
5.30
6.6
3.6
0.32
0.40
e9/l
0.48
31
118
289
2094
1.41
5.20
7.2
3.9
0.16
0.22
e6/l
0.61
225
1479
74
394
1.81
5.10
8.2
8.0
396.16
295.81
mg/l
0.37
57
306
794
6857
1.60
5.05
18.7
9.9
57.76
60.37
umol/l
1.15
781
6750
203
1395
1.45
4.85
3.9
2.9
61.38
55.69
u/l
0.78
195
1307
308
2294
1.37
4.59
7.2
3.9
12.20
43.65
e6/l
1.72
239
1668
22
74
2.80
4.58
3.0
2.4
156.23
167.15
ug/g
0.16
22
65
159
1054
1.48
4.55
1.7
1.4
22.93
18.80
nmol/l
2.84
149
949
51
250
1.94
4.54
16.4
24.6
16.00
15.71
%
0.30
51
243
25
91
2.59
4.50
8.2
3.4
27.97
39.52
mmol/l
1.35
25
91
813
7097
1.62
4.48
13.4
8.3
—
—
—
0
0
103
623
1.60
4.46
1.8
1.4
—
—
—
0
0
16
45
3.34
4.46
2.1
1.9
0.33
0.25
iu/ml
0.19
11
31
16
45
3.34
4.46
1.3
1.4
—
—
—
0
0
108
666
1.57
4.32
2.5
1.8
—
—
—
0
0
59
310
1.82
4.27
2.4
1.7
—
—
—
0
0
22
77
2.69
4.27
7.3
8.1
5.35
5.23
pmol/l
0.04
22
77
32
135
2.24
4.22
1.5
1.4
—
—
—
0
0
886
7959
2.67
4.18
29.2
17.2
4.56
4.61
e12/l
2.98
867
7654
194
1357
1.41
4.16
6.6
3.6
2.79
2.50
e6/l
0.15
110
691
176
1211
1.43
4.13
7.3
4.0
—
—
—
0
0
179
1236
1.43
4.12
18.3
9.2
—
—
—
0
0
14
38
3.45
4.12
3.4
1.9
—
—
—
0
0
35
155
2.14
4.11
6.2
8.3
1555.02
71.60
mg/mmol
0.50
30
145
35
155
2.14
4.11
4.1
2.0
0.94
1.16
g/l
0.77
29
141
886
7963
2.64
4.10
29.3
17.3
6.87
7.00
e9/l
0.65
868
7657
885
7954
2.55
4.01
29.3
17.3
275.05
269.16
e9/l
1.77
867
7668
82
483
1.63
3.97
7.2
5.9
0.78
0.79
%
0.01
32
138
139
924
1.47
3.91
2.3
1.7
—
—
—
0
0
365
2845
1.32
3.86
8.8
4.8
27.93
45.58
e6/l
1.27
254
1763
192
1361
1.39
3.79
6.3
3.5
0.58
0.88
e6/l
1.42
108
695
34
155
2.07
3.73
1.4
1.4
—
—
—
0
0
236
1734
1.35
3.72
3.2
2.3
—
—
—
0
0
78
462
1.62
3.70
5.9
5.4
0.38
0.51
%
0.42
29
141
234
1720
1.35
3.67
2.1
1.6
98.39
96.10
pmol/l
0.41
128
956
65
369
1.68
3.64
3.4
2.1
97.21
103.58
au/ml
0.17
28
137
55
299
1.75
3.59
18.0
22.5
95.61
95.13
%
0.22
55
299
732
6320
1.39
3.59
24.3
12.1
139.33
139.37
mmol/l
0.26
715
6149
80
481
1.59
3.58
7.3
6.1
0.04
0.04
%
0.01
26
124
177
1249
1.39
3.58
5.2
4.3
2.13
1.35
mg/l
0.52
135
878
65
373
1.66
3.50
3.3
2.1
—
—
—
0
0
462
3751
1.29
3.48
14.0
7.9
5.79
6.04
mmol/l
1.56
438
3413
442
3569
1.29
3.48
5.4
3.5
0.04
0.00
estimate
0.49
82
652
68
396
1.64
3.47
15.8
19.1
16.01
15.74
kpa
0.12
68
388
730
6312
1.37
3.44
24.7
12.1
3.94
3.92
mmol/l
1.06
709
6115
9
16
5.25
3.43
1.1
1.3
146.78
130.19
nmol/l
—
9
16
68
398
1.63
3.40
15.8
19.1
7.41
7.39
ph
0.42
18
133
25
105
2.24
3.37
2.3
1.5
5.45
12.99
u/ml
0.91
20
87
113
743
1.47
3.37
2.4
2.0
—
—
—
0
0
81
498
1.56
3.31
3.0
1.8
233.49
165.43
u/ml
1.16
51
242
67
395
1.62
3.27
16.0
19.2
-1.45
-0.16
mmol/l
1.65
59
333
53
294
1.71
3.25
18.5
22.8
0.63
0.70
%
0.94
53
294
194
1418
1.34
3.12
19.5
9.3
7.41
7.41
ph
0.12
167
1127
437
3558
1.27
3.09
5.3
3.5
0.00
2.30
estimate
0.50
76
656
93
599
1.49
3.08
2.3
2.5
28.90
28.68
u/l
0.02
86
489
178
1288
1.35
3.06
18.2
9.0
23.94
24.04
mmol/l
0.28
178
1281
17
63
2.53
3.01
1.6
1.3
—
—
—
0
0
89
574
1.48
2.94
1.7
1.5
412.47
316.73
mu/l
0.83
82
510
55
319
1.64
2.89
13.3
18.2
121.87
121.40
g/l
0.05
55
313
75
469
1.53
2.87
7.6
5.9
0.00
0.04
%
1.23
24
124
8
16
4.66
2.85
1.3
1.0
53.33
69.69
nmol/24h
—
8
16
5
5
9.31
2.84
1.4
2.0
—
—
—
0
0
21
89
2.21
2.81
4.2
3.9
1.88
3.41
%
—
8
36
123
851
1.39
2.79
12.8
7.0
4.68
6.29
umol/l
1.44
104
698
431
3539
1.25
2.71
5.3
3.4
0.00
0.00
estimate
-0.00
79
674
106
720
1.41
2.68
1.4
1.3
134.19
153.49
u/ml
0.16
33
236
12
37
3.03
2.68
3.1
2.1
29.67
32.05
pg
0.65
12
37
48
276
1.65
2.62
3.3
2.0
3.15
6.25
iu/ml
—
10
41
5
6
7.76
2.61
1.2
1.2
61.00
71.00
ug/l
—
5
6
20
86
2.18
2.60
2.0
1.8
—
—
—
0
0
35
185
1.78
2.58
2.8
2.5
—
—
—
0
0
107
735
1.40
2.54
3.1
2.5
4.26
4.40
e9/l
0.18
100
676
37
203
1.72
2.42
1.4
1.7
0.49
0.74
g/l
1.69
32
180
37
204
1.71
2.38
1.1
1.1
0.57
6.56
eliau/ml
—
6
70
34
184
1.74
2.34
1.5
1.3
—
9.62
—
0
13
92
629
1.40
2.27
1.6
1.4
496.20
32495940.65
pmol/l
1.05
87
557
27
138
1.84
2.24
5.2
5.5
7.40
7.39
ph
0.19
27
138
75
497
1.43
2.20
2.3
2.0
6.24
6.38
ph
0.73
46
326
8
22
3.39
2.18
2.8
2.4
—
—
—
0
0
21
100
1.97
2.14
1.7
1.3
—
—
—
0
0
63
407
1.47
2.12
5.2
4.0
10.27
8.93
umol/l
0.28
54
333
9
28
3.00
2.11
2.9
2.9
264.44
268.25
e6/l
—
9
28
41
241
1.60
2.10
7.6
4.8
1.23
1.23
mmol/l
0.05
36
206
125
909
1.32
2.09
2.5
1.6
—
—
—
0
0
27
142
1.79
2.07
3.3
1.7
—
—
—
0
0
21
102
1.93
2.04
1.7
1.2
—
—
—
0
0
27
143
1.77
2.02
1.3
1.5
2.73
4.52
u/ml
1.13
15
80
218
1708
1.24
2.00
4.4
3.3
0.00
0.00
estimate
0.80
78
640
143
1066
1.29
1.99
8.7
6.9
30.36
30.77
s
0.42
138
1056
7
19
3.43
1.99
3.1
2.4
11.00
11.84
%
—
7
19
9
30
2.80
1.96
20.8
11.3
—
—
—
0
0
62
407
1.44
1.94
1.5
1.6
—
—
—
0
0
20
98
1.91
1.91
7.0
9.3
1.39
1.44
%
0.11
20
87
7
20
3.26
1.90
2.9
2.4
31.86
25.45
%
—
7
20
25
133
1.76
1.86
3.6
1.9
291.70
295.86
mosm/kgh2o
0.56
20
94
35
206
1.60
1.82
3.0
4.2
6.83
7.44
index
0.06
24
131
7
21
3.10
1.81
1.9
2.0
—
—
—
0
0
41
251
1.54
1.81
3.1
2.2
1.02
1.02
ratio
0.01
31
211
48
631
0.69
1.75
1.2
1.4
3.50
3.24
mmol/l
0.50
28
390
196
1545
1.22
1.69
6.2
5.1
1.10
1.13
inr
0.28
162
1282
216
1720
1.21
1.69
5.5
4.8
6.89
8.71
mmol/l
5.76
202
1614
208
1656
1.21
1.63
3.8
3.0
1.02
1.02
kg/l
0.41
143
1059
71
494
1.36
1.63
2.3
1.9
0.00
0.00
estimate
-0.00
11
127
58
390
1.40
1.63
1.5
1.5
1085.02
1084.62
nmol/l
0.00
45
299
20
104
1.80
1.63
5.8
5.9
9.91
9.34
kpa
0.56
20
104
20
104
1.80
1.63
5.8
6.3
5.23
4.76
kpa
2.42
20
104
20
104
1.80
1.63
5.8
6.3
2.10
1.71
mmol/l
0.39
13
52
6
18
3.10
1.61
1.0
1.2
—
—
—
0
0
8
30
2.48
1.56
1.9
1.5
—
—
—
0
0
511
4408
1.17
1.55
6.2
3.9
22.40
1334.41
e6/l
—
5
41
12
53
2.11
1.52
1.2
1.2
—
—
—
0
0
17
86
1.85
1.51
7.3
10.0
0.88
0.88
%
0.01
17
77
196
1563
1.21
1.51
6.9
4.9
—
—
—
0
0
19
100
1.78
1.50
2.3
2.9
—
—
—
0
0
20
107
1.75
1.50
1.2
1.1
—
—
—
0
0
62
429
1.36
1.49
1.1
1.1
0.87
0.71
u/ml
0.07
32
221
13
60
2.02
1.48
1.0
1.1
1117.15
1669.33
miu/ml
0.87
13
60
13
60
2.02
1.48
1.2
1.7
—
—
—
0
0
9
35
2.40
1.46
1.4
1.1
—
—
—
0
0
6
20
2.79
1.45
1.3
1.6
—
—
—
0
0
291
2413
1.17
1.43
4.2
3.0
0.00
0.01
estimate
1.08
68
559
175
1880
0.83
1.43
1.9
1.9
—
—
—
0
0
348
2928
1.16
1.42
2.5
2.3
—
—
—
0
0
37
235
1.48
1.42
2.4
1.8
0.00
0.00
estimate
-0.00
11
97
23
131
1.64
1.40
5.3
5.5
—
—
—
0
0
15
75
1.87
1.39
2.3
2.0
—
—
—
0
0
11
49
2.09
1.38
1.1
1.3
—
—
—
0
0
353
2990
1.15
1.30
5.0
3.2
6.37
6.33
ph
0.29
168
1437
224
1834
1.17
1.28
2.2
1.9
1.26
1.21
mmol/l
0.43
214
1704
42
282
1.40
1.24
1.3
1.2
—
—
—
0
0
92
693
1.26
1.23
1.1
1.2
5.67
6.00
u/ml
0.08
68
526
16
86
1.74
1.21
1.3
1.2
—
—
—
0
0
62
446
1.31
1.19
1.1
1.2
9.78
10.99
u/ml
0.16
45
286
19
108
1.64
1.19
2.8
8.8
—
—
—
0
0
15
80
1.75
1.17
1.3
1.1
—
—
—
0
0
91
1021
0.81
1.16
2.0
2.1
—
—
—
0
0
8
36
2.07
1.15
1.0
1.3
—
—
—
0
0
98
1090
0.81
1.15
2.0
2.1
—
—
—
0
0
103
793
1.23
1.15
2.8
3.8
875.58
1220.19
ng/l
0.43
48
414
37
247
1.40
1.14
4.0
4.5
—
—
—
0
0
99
1098
0.82
1.13
1.9
2.1
—
—
—
0
0
5
19
2.45
1.11
1.4
1.6
—
—
—
0
0
99
1095
0.82
1.10
2.0
2.1
—
—
—
0
0
98
1085
0.82
1.10
1.9
2.1
—
—
—
0
0
7
130
0.49
1.10
1.4
1.7
0.44
0.49
e9/l
—
7
130
7
29
2.25
1.09
2.3
1.5
69.14
63.10
umol/l
—
7
29
15
83
1.69
1.05
4.9
4.0
0.53
0.59
%
0.09
15
72
246
2064
1.14
1.01
6.4
4.7
29.31
31.63
u/l
0.89
235
1986
26
167
1.46
1.00
44.1
22.1
11.28
11.71
%
0.25
26
167
56
409
1.29
0.99
1.4
1.2
—
—
—
0
0
0
29
0.00
0.97
0.0
1.0
—
0.57
—
0
22
40
280
1.34
0.96
1.1
1.2
—
—
—
0
0
7
34
1.91
0.94
1.1
2.1
1800.00
1852.71
ml
—
7
34
88
683
1.21
0.94
1.1
1.2
1.89
1.11
u/ml
0.25
59
473
6
25
2.23
0.93
1.3
1.2
4.02
1.55
nmol/l
—
6
25
58
430
1.27
0.93
1.3
1.3
—
—
—
0
0
16
94
1.59
0.91
3.9
5.8
0.56
0.73
index
0.26
16
94
12
65
1.72
0.91
1.3
1.2
—
—
—
0
0
63
473
1.25
0.91
1.1
1.1
8.61
7.63
u/ml
0.12
46
315
524
4628
1.12
0.89
3.0
2.5
5.20
5.36
mmol/l
4.86
501
4310
34
237
1.34
0.85
1.2
1.2
—
—
—
0
0
12
67
1.67
0.83
1.6
1.5
—
—
—
0
0
252
2146
1.12
0.82
5.1
2.9
—
—
—
0
0
26
175
1.39
0.81
1.0
1.1
—
—
—
0
0
36
256
1.32
0.80
4.2
4.4
635.00
16659.32
e6/l
0.50
26
185
36
256
1.32
0.80
4.1
4.4
9.42
14.99
e6/l
0.35
26
177
23
154
1.39
0.75
12.8
7.8
37.02
37.00
°c
0.08
23
154
10
55
1.69
0.74
2.0
1.3
—
—
—
0
0
10
55
1.69
0.74
2.0
1.3
—
—
—
0
0
10
55
1.69
0.74
2.0
1.3
—
—
—
0
0
34
244
1.30
0.73
1.1
1.2
2.89
6.55
iu/ml
—
8
40
7
36
1.81
0.73
1.3
1.2
—
—
nmol/l
—
0
0
5
24
1.94
0.71
1.6
1.7
—
—
—
0
0
31
221
1.31
0.70
1.4
1.5
—
—
—
0
0
93
750
1.17
0.69
1.2
1.3
3.35
3.09
u/ml
0.07
65
527
120
987
1.15
0.68
2.1
1.6
575.38
544.21
titre
0.06
26
152
110
900
1.15
0.67
1.3
1.3
27.41
14.41
iu/ml
0.56
18
181
14
87
1.50
0.66
2.2
1.9
19.22
29.92
mg/l
—
9
48
231
2306
0.90
0.66
1.8
2.0
—
—
—
0
0
216
1850
1.11
0.64
3.9
2.6
0.00
0.01
estimate
0.88
70
556
14
88
1.48
0.64
1.4
1.1
—
—
—
0
0
84
677
1.16
0.63
1.1
1.2
3.07
3.16
u/ml
0.03
64
487
451
4358
0.92
0.63
3.9
2.7
1.13
1.09
mmol/l
0.79
440
4188
5
27
1.72
0.63
2.4
4.6
25.00
85.26
u/l
—
5
27
8
45
1.65
0.62
9.1
7.6
—
—
—
0
0
101
827
1.15
0.62
1.3
1.2
5.29
5.17
u/ml
0.01
34
278
494
4751
0.92
0.61
4.1
2.9
1.44
1.42
mmol/l
0.42
481
4569
9
128
0.65
0.61
1.2
1.5
—
221.43
—
0
7
194
1657
1.11
0.60
2.0
1.7
—
—
—
0
0
13
82
1.48
0.59
2.2
1.7
6193.63
22463.02
e6/l
—
8
59
6
32
1.74
0.58
4.7
2.0
—
—
—
0
0
52
407
1.19
0.56
1.1
1.1
—
—
—
0
0
6
34
1.64
0.56
1.3
1.4
149.97
209.12
pmol/l
—
6
34
6
35
1.59
0.54
4.8
2.0
—
—
—
0
0
6
36
1.55
0.53
1.0
1.5
25.33
28.39
s
—
6
36
9
59
1.42
0.52
1.3
1.9
—
—
—
0
0
7
42
1.55
0.49
1.3
1.0
1.09
1.05
ratio
—
7
36
25
184
1.27
0.48
1.9
1.5
37.76
39.82
nmol/l
0.20
25
178
34
260
1.22
0.48
4.2
4.4
7.38
7.32
ph
1.91
26
191
46
496
0.85
0.46
2.7
2.8
—
—
—
0
0
502
4792
0.93
0.46
4.1
3.0
2.68
2.67
mmol/l
0.19
490
4603
38
297
1.19
0.44
1.2
1.2
—
—
—
0
0
506
4824
0.94
0.44
4.2
3.0
4.46
4.42
mmol/l
0.45
495
4661
11
72
1.42
0.43
1.0
1.0
—
—
—
0
0
11
72
1.42
0.43
1.0
1.1
—
—
—
0
0
39
423
0.85
0.43
1.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
3.7
—
0.46
—
0
16
8
56
1.33
0.40
6.5
3.4
—
—
—
0
0
5
32
1.45
0.40
1.2
1.1
—
—
—
0
0
21
239
0.81
0.38
1.4
1.1
—
—
—
0
0
28
217
1.20
0.37
1.4
1.2
13.40
226.32
iu/ml
—
5
71
330
2943
1.06
0.36
4.8
3.3
—
—
estimate
—
0
0
24
266
0.83
0.35
1.1
1.0
—
0.61
—
0
16
6
41
1.36
0.34
4.2
6.0
216.83
198.21
ug/l
—
6
41
25
194
1.20
0.33
5.3
5.3
—
—
—
0
0
10
69
1.35
0.31
1.1
1.1
—
—
—
0
0
7
50
1.30
0.30
1.1
1.2
—
—
nmol/l
—
0
0
15
111
1.26
0.30
3.3
3.7
1.60
4.92
ug/l
—
8
64
160
1404
1.07
0.30
1.9
1.6
—
—
—
0
0
11
78
1.31
0.29
1.2
1.2
0.56
0.58
ratio
—
5
45
20
155
1.20
0.28
4.1
4.4
—
—
—
0
0
8
58
1.28
0.28
3.1
2.1
—
—
—
0
0
18
138
1.21
0.28
3.9
3.6
3.01
3.50
e9/l
0.60
18
138
301
2880
0.95
0.27
2.0
1.8
—
—
—
0
0
81
696
1.09
0.26
4.2
4.4
292.83
88.18
mg/l
0.47
62
554
36
297
1.13
0.25
3.4
2.6
48.98
54.27
%
1.34
36
297
28
228
1.14
0.23
1.7
1.5
—
—
—
0
0
5
35
1.33
0.23
1.0
1.1
—
—
—
0
0
33
273
1.12
0.22
1.4
1.5
8.63
3.01
u/ml
0.92
22
197
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
86.40
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
45.78
—
0
5
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
270
2432
1.04
0.20
2.0
1.9
—
—
—
0
0
6
45
1.24
0.20
1.0
1.2
—
—
—
0
0
103
906
1.06
0.20
2.2
2.3
—
—
—
0
0
6
48
1.16
0.19
1.0
1.0
—
—
—
0
0
12
92
1.21
0.19
1.5
2.3
10.30
9.37
mg/l
0.39
12
87
10
113
0.82
0.19
11.7
6.7
—
—
—
0
0
55
546
0.93
0.18
5.2
3.4
—
—
—
0
0
11
84
1.22
0.18
1.5
1.3
0.54
0.45
ug/l
—
5
17
322
3049
0.97
0.18
2.3
2.4
—
—
—
0
0
16
128
1.16
0.17
1.9
2.5
—
—
—
0
0
27
275
0.91
0.15
1.1
1.0
1.52
1.50
g/l
0.14
27
275
58
506
1.07
0.15
2.2
2.2
7.30
15.37
au/ml
—
6
58
97
861
1.05
0.15
1.6
1.5
—
—
—
0
0
7
82
0.79
0.14
1.0
1.2
0.39
4.19
u/ml
—
7
71
72
699
0.95
0.13
1.7
1.6
73.42
58.70
ug/l
1.40
60
622
118
1056
1.04
0.13
2.3
2.3
18.92
60.14
ng/l
0.99
37
366
53
518
0.94
0.12
1.6
1.3
—
—
—
0
0
15
123
1.13
0.12
1.1
1.1
1.41
1.38
g/l
0.24
15
116
15
124
1.12
0.11
1.0
1.1
—
—
—
0
0
15
124
1.12
0.11
3.9
9.6
23.93
23.19
mmol/l
0.23
15
117
30
298
0.93
0.11
1.5
1.5
—
—
—
0
0
12
126
0.88
0.11
1.2
1.3
6.92
8.10
u/ml
0.07
12
117
6
50
1.11
0.09
2.0
2.8
15.05
17.73
umol/l
—
6
50
12
124
0.90
0.08
1.3
1.3
0.30
13.71
u/ml
4.20
12
116
14
143
0.91
0.08
1.1
1.1
—
—
—
0
0
7
59
1.10
0.08
1.0
1.0
—
—
—
0
0
439
4032
1.02
0.08
6.5
4.1
24.97
26.47
u/l
0.54
422
3905
18
154
1.08
0.07
1.1
1.1
—
—
—
0
0
27
265
0.94
0.07
1.4
1.6
6.45
15.40
u/ml
0.57
15
179
56
501
1.04
0.07
1.7
1.5
1.19
1.27
mm
1.21
43
383
11
112
0.91
0.05
1.2
1.1
—
—
—
0
0
24
233
0.95
0.04
1.7
1.7
3.77
5.49
u/ml
—
6
57
14
139
0.93
0.04
2.4
2.5
1.13
2.14
mmol/l
—
9
113
769
7141
0.98
0.04
20.7
11.2
20.68
22.34
mg/l
0.82
599
5301
76
691
1.02
0.04
5.1
5.0
212.69
10.65
mg/mmol
0.51
56
545
59
535
1.02
0.03
2.0
1.3
—
—
—
0
0
22
213
0.96
0.03
3.5
2.0
76.67
61.50
titre
—
6
20
10
85
1.09
0.03
10.1
4.2
1.44
1.71
mmol/l
—
10
85
20
177
1.05
0.03
2.3
2.2
56.25
34.13
u/ml
0.41
20
171
37
334
1.03
0.02
1.3
1.3
—
—
—
0
0
15
132
1.05
0.02
1.5
1.9
—
—
—
0
0
56
527
0.98
0.02
1.3
1.3
237.38
242.86
miu/ml
0.04
29
270
29
276
0.97
0.01
1.1
1.0
0.95
0.85
g/l
0.56
29
276
78
731
0.99
0.01
1.8
2.0
—
—
—
0
0
139
1295
0.99
0.01
1.7
1.7
1282.27
961.68
mu/l
2.30
123
1164
23
219
0.97
0.01
1.1
1.3
0.76
2.67
u/ml
0.92
12
145
26
235
1.03
0.01
2.2
2.3
1.65
3.38
iu/l
2.94
12
107
27
256
0.98
0.00
1.0
1.0
—
—
—
0
0
27
256
0.98
0.00
1.0
1.0
-1.06
-2.16
mmol/l
—
5
53
18
166
1.00
0.00
1.0
1.1
—
—
—
0
0
41
379
1.00
0.00
1.6
1.7
0.19
0.20
mg/l
0.04
12
156
56
521
1.00
0.00
1.9
1.6
—
—
—
0
0
57
528
1.00
0.00
1.2
1.2
—
—
—
0
0
10
95
0.97
0.00
1.1
1.1
25.94
32.62
iu/ml
—
10
95
104
968
0.99
0.00
2.8
2.5
13501.00
8150.17
u/l
0.38
38
371
56
517
1.00
0.00
1.8
1.5
—
—
—
0
0
35
328
0.99
0.00
1.5
1.3
—
—
—
0
0
35
327
0.99
0.00
1.5
1.3
—
—
—
0
0
36
332
1.00
0.00
1.0
1.0
11.25
8.43
mu/l
0.68
30
286
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
59
0.94
-0.00
8.8
3.5
5.32
4.94
kpa
—
6
59
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1.47
—
0
5
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
8460.00
—
0
5
0
5
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
462.04
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_SHORT – Short stature, not elsewhere classified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).